Publications and communications of Etienne CAVALIER

Pottel, H., Delanaye, P., & Cavalier, E. (01 March 2024). Exploring Renal Function Assessment: Creatinine, Cystatin C, and Estimated Glomerular Filtration Rate Focused on the European Kidney Function Consortium Equation. Annals of Laboratory Medicine, 44 (2), 135 - 143. doi:10.3343/alm.2023.0237

Huyghebaert, L., Massonnet, P., Grifnée, E., Demeuse, J., Peeters, S., Dubrowski, T., Schoumacher, M., Cavalier, E., & Le Goff, C. (31 January 2024). Simultaneous detection and quantification of gastrin 17 and 34 sulfated and non-sulfated forms by LC-MS/MS in human plasma [Poster presentation]. CIRM Day 2024, Liège, Belgium.

Pittie, G., LUKAS, P., MASSART, M., Cavalier, E., & Le Goff, C. (2023). Evaluation of analytical and clinical performance of the AFIAS Tn-I plus assay -a new point-of-care. Acta Cardiologica, 1-7. doi:10.1080/00015385.2023.2286423

Jørgensen, H. S., Claes, K., Smout, D., Naesens, M., Kuypers, D., D'Haese, P., Cavalier, E., & Evenepoel, P. (2023). Associations of Changes in Bone Turnover Markers with Change in Bone Mineral Density in Kidney Transplant Patients. Clinical Journal of the American Society of Nephrology. doi:10.2215/CJN.0000000000000368

Huyghebaert, L., Massonnet, P., Grifnée, E., Demeuse, J., Dubrowski, T., Schoumacher, M., Peeters, S., Cavalier, E., & Le Goff, C. (17 November 2023). Simultaneous detection and quantification of gastrin 17 and 34 sulfated and non-sulfated forms by LC-MS/MS in human plasma [Poster presentation]. RBSLM, Bruxelles, Belgium.

Cavalier, E., Farre Segura, J., LUKAS, P., GENDEBIEN, A.-S., Peeters, S., Massonnet, P., Le Goff, C., Bouquegneau, A., Souberbielle, J.-C., Delatour, V., & Delanaye, P. (2023). Unveiling a new era with liquid chromatography coupled with mass spectrometry to enhance parathyroid hormone measurement in patients with chronic kidney disease. Kidney International. doi:10.1016/j.kint.2023.09.033

Misset, B., Nguyet, A. D., BERTRAND, A., Piagnerelli, M., Hoste, E., de Waele, E., Dumoulin, A., Jorens, P., van der Hauwaert, E., Vallot, F., Swinnen, W., De Schryver, N., de Mey, N., Layios, N., Mesland, J., Robinet, S., Cavalier, E., Donneau, A.-F., Moutschen, M., & Laterre, P. F. (24 October 2023). Immunological sub-phenotypes and response to Convalescent-Plasma (CP) in COVID-19 induced ARDS (C-ARDS): a hierarchical cluster analysis [Poster presentation]. ESICM LIVES 2023, Milan, Italy.

Rousseau, A.-F., Ngongan, A., COLSON, C., MINGUET, P., NEIS GILSON, S., Cavalier, E., MINGUET, G., Misset, B., & Boemer, F. (16 August 2023). Mid-Term Evolution of the Serum Acylcarnitine Profile in Critically Ill Survivors: A Metabolic Insight into Survivorship. Nutrients, 15 (16), 3595. doi:10.3390/nu15163595

Ledeck, J., Peeters, S., Le Goff, C., Deleuze, S., Cavalier, E., & Ponthier, J. (June 2023). Cortisol and DHEA as markers of placentitis in pregnant mares: a preliminary study. Journal of Equine Veterinary Science, 125. doi:10.1016/j.jevs.2023.104773

van Londen, M., Bökenkamp, A., Cavalier, E., Delanaye, P., & Ebert, N. (June 2023). #4179 DIFFERENCES IN PROTOCOLS FOR MEASURING GLOMERULAR FILTRATION RATE USING IOHEXOL. Nephrology Dialysis Transplantation, 38 (Supplement_1). doi:10.1093/ndt/gfad063d_4179

Pincemail, J., Rousseau, A.-F., Kaux, J.-F., CHERAMY-BIEN, J.-P., Bruyere, C., PRICK, J., Stern, D., Kaci, M.-M., MAERTENS DE NOORDHOUT, B., Albert, A., Eubelen, C., Le Goff, C., Misset, B., Cavalier, E., Charlier, C., & Meziane, S. (April 2023). A Pilot Study on Oxidative Stress during the Recovery Phase in Critical COVID-19 Patients in a Rehabilitation Facility: Potential Utility of the PAOT ® Technology for Assessing Total Anti-Oxidative Capacity. Biomedicines, 11 (5), 1308. doi:10.3390/biomedicines11051308

Cavalier, E., Fraser, C. G., Bhattoa, H. P., Heijboer, A. C., Makris, K., Vasikaran, S., Huyghebaert, L., Peeters, S., Le Goff, C., Herrmann, M., Carobene, A., & IFCC-IOF Committee for Bone Metabolisma. (31 March 2023). Analytical performance specifications for the measurement uncertainty of 24,25-dihydroxyvitamin D examinations. Clinical Chemistry and Laboratory Medicine, 0 (0). doi:10.1515/cclm-2023-0176

Delanaye, P., Cavalier, E., Pottel, H., & Stehlé, T. (15 March 2023). New and old GFR equations: a European perspective. Clinical Kidney Journal, 16 (9), 1375-1383. doi:10.1093/ckj/sfad039

Dirks, N. F., Cavalier, E., & Heijboer, A. C. (15 March 2023). Vitamin D: marker, measurand and measurement. Endocrine Connections, 12 (4). doi:10.1530/EC-22-0269

Huyghebaert, L., Demeuse, J., Determe, W., Farre Segura, J., Peeters, S., Grifnee, E., Massonnet, P., Dubrowski, T., Schoumacher, M., Cavalier, E., & Le Goff, C. (01 February 2023). Simultaneous detection and quantification of angiotensin 1-7, 1-8, 1-9 and 1-10 by LC-MS/MS in human plasma [Poster presentation]. CIRM Day 2023, Liège, Belgium.

Massonnet, P., Henri, L.-A., Farre Segura, J., Peeters, S., Grifnee, E., Demeuse, J., Huyghebaert, L., Dubrowski, T., Schoumacher, M., Le Goff, C., & Cavalier, E. (01 February 2023). Characterization of intact Parathyroid hormone and its fragments by Liquid Chromatography coupled to High-Resolution Mass Spectrometry [Poster presentation]. CIRM day 2023.

Delanaye, P., Schaeffner, E., Cozzolino, M., Langlois, M., Plebani, M., Ozben, T., & Cavalier, E. (27 January 2023). The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clinical Chemistry and Laboratory Medicine, 61 (1), 44 - 47. doi:10.1515/cclm-2022-0928

Delanaye, P., Vidal-Petiot, E., Björk, J., Ebert, N., Eriksen, B. O., Dubourg, L., Grubb, A., Hansson, M., Littmann, K., Mariat, C., Melsom, T., Schaeffner, E., Sundin, P.-O., Bökenkamp, A., Berg, U. B., Åsling-Monemi, K., Åkesson, A., Larsson, A., Cavalier, E., ... Flamant, M. (23 January 2023). Performance of creatinine-based equations to estimate glomerular filtration rate in White and Black populations in Europe, Brazil and Africa. Nephrology Dialysis Transplantation, 38 (1), 106 - 118. doi:10.1093/ndt/gfac241

Huybrechts, Y., Evenepoel, P., Haarhaus, M., Cavalier, E., Dams, G., Van Hul, W., D'Haese, P. C., & Verhulst, A. (23 January 2023). Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover. Nutrients, 15 (3), 598. doi:10.3390/nu15030598

Ladang, A., Beaudart, C., Reginster, J.-Y., Al-Daghri, N., Bruyère, O., Burlet, N., Cesari, M., Cherubini, A., da Silva, M. C., Cooper, C., Cruz-Jentoft, A. J., Landi, F., Laslop, A., Maggi, S., Mobasheri, A., Ormarsdottir, S., Radermecker, R., Visser, M., Yerro, M. C. P., ... Cavalier, E. (12 January 2023). Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging. Calcified Tissue International, online. doi:10.1007/s00223-022-01054-z

Fuggle, N., Al-Daghri, N., Bock, O., Branco, J., Bruyère, O., Casado, E., Cavalier, E., Cortet, B., de Wit, M., Giusti, A., Halbout, P., Harvey, N. C., Hiligsmann, M., Kaufman, J.-M., Kurth, A., Maggi, S., Matijevic, R., Minisola, S., Palacios, S., ... Cooper, C. (03 January 2023). Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis. Aging Clinical and Experimental Research, online. doi:10.1007/s40520-022-02319-1

Beaudart, C., Sanchez Rodriguez, M. D. C., Demonceau, C., Cavalier, E., Reginster, J.-Y., & Bruyère, O. (2023). Screening for malnutrition by the MNA-SF, diagnosis by the Global Leadership Initiative on Malnutrition (GLIM) criteria, or both? Predictive capacity for mortality in a 9-year follow-up in the SarcoPhAge cohort. Aging Clinical and Experimental Research, 35 (suppl 1), 335.

Beaudart, C., Sanchez Rodriguez, M. D. C., Demonceau, C., Cavalier, E., Reginster, J.-Y., & Bruyère, O. (2023). Intrinsic capacity using the MNA-SF and the Global Leadership Initiative of Malnutrition (GLIM) criteria in the nutritional domain and mortality-risk: A 9-year follow-up in the SarcoPhAge cohortr. Aging Clinical and Experimental Research, 35 (suppl 1), 334-S335.

Delanaye, P., Lanot, A., Bouquegneau, A., Warling, X., Radermacher, L., Masset, C., Krzesinski, J.-M., Moranne, O., & Cavalier, E. (January 2023). Monitoring 25-OH and 1,25-OH vitamin D levels in hemodialysis patients after starting therapy: Does it make sense? Clinica Chimica Acta, 539, 50-54. doi:10.1016/j.cca.2022.11.032

Dufour, P., Grifnee, E., BREVERS, E., Paquot, N., Le Goff, C., Cavalier, E., & Ladang, A. (18 November 2022). LABORATORY EXPLORATION OF A VERY HIGH LEVEL OF INSULIN MEASURED IN A LONG-STANDING TYPE 1 DIABETIC PATIENT [Poster presentation]. 2022 Annual RBSLM Meeting.

Farre Segura, J., Le Goff, C., LUKAS, P., Cobraiville, G., Fillet, M., Servais, A.-C., Delanaye, P., & Cavalier, E. (03 November 2022). Validation of an LC-MS/MS Method Using Solid-Phase Extraction for the Quantification of 1-84 Parathyroid Hormone: Toward a Candidate Reference Measurement Procedure. Clinical Chemistry, 68 (11), 1399-1409. doi:10.1093/clinchem/hvac135

Snoeck, A., Jaffey, J., Billen, F., Peeters, S., Le Goff, C., Peeters, D., Fernandes Rodrigues, N., Cavalier, E., & Clercx, C. (03 November 2022). Serum 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in dogs with sinonasal aspergillosis. Journal of Veterinary Internal Medicine, 36, 2455-2551.

Chevalley, T., Brandi, M. L., Cashman, K. D., Cavalier, E., Harvey, N. C., Maggi, S., Cooper, C., Al-Daghri, N., Bock, O., Bruyère, O., Rosa, M. M., Cortet, B., Cruz-Jentoft, A. J., Cherubini, A., Dawson-Hughes, B., Fielding, R., Fuggle, N., Halbout, P., Kanis, J. A., ... Rizzoli, R. (November 2022). Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clinical and Experimental Research, 34 (11), 2603 - 2623. doi:10.1007/s40520-022-02279-6

Fuggle, N., Al-Daghri, N., Bock, O., Branco, J., Bruyère, O., Casado, E., Cavalier, E., Cortet, B., de Wit, M., Giusti, A., Halbout, P., Harvey, N. C., Hiligsmann, M., Kaufman, J.-M., Kurth, A., Maggi, S., Matijevic, R., Minisola, S., Palacios, S., ... Cooper, C. (November 2022). Novel formulations of oral bisphosphonates in the treatment of osteoporosis. Aging Clinical and Experimental Research, 34 (11), 2625 - 2634. doi:10.1007/s40520-022-02272-z

Nateghi Haredasht, F., Antonatou, M., Cavalier, E., Delanaye, P., Pottel, H., & Makris, K. (November 2022). The effect of different consensus definitions on diagnosing acute kidney injury events and their association with in-hospital mortality. Journal of Nephrology, 35 (8), 2087-2095. doi:10.1007/s40620-022-01323-y

Castiglione, V., Berodes, M., LUKAS, P., Louis, E., Cavalier, E., & Lutteri, L. (27 September 2022). New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method. Diagnostics, 12 (10), 2338. doi:10.3390/diagnostics12102338

Veronese, N., Cooper, C., Bruyère, O., Al-Daghri, N., Branco, J., Cavalier, E., Cheleschi, S., da Silva Rosa, M. C., Conaghan, P. G., Dennison, E. M., de Wit, M., Fioravanti, A., Fuggle, N. R., Haugen, I. K., Herrero-Beaumont, G., Honvo, G., Laslop, A., Matijevic, R., Migliore, A., ... Reginster, J.-Y. (16 September 2022). Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations. Drugs, 82 (13), 1347-1355. doi:10.1007/s40265-022-01773-5

Rousseau, A.-F., LUCANIA, S., FADEUR, M., Verbrugge, A.-M., Cavalier, E., COLSON, C., & Misset, B. (15 September 2022). Adequacy of Nutritional Intakes during the Year after Critical Illness: An Observational Study in a Post-ICU Follow-Up Clinic. Nutrients, 14 (18), 3797. doi:10.3390/nu14183797

Ledeck, J., Dufour, P., Evrard, E., LE GOFF, C., PEETERS, S., Brutinel, F., Egyptien, S., Deleuze, S., CAVALIER, E., & Ponthier, J. (September 2022). Evolution of 17-ß-Estradiol, Estrone and Estrone-Sulfate concentrations in late pregnancy of different breeds of mares using Liquid Chromatography and Mass Spectrometry. Theriogenology, 189, 86-91. doi:10.1016/j.theriogenology.2022.06.004

Tostivint, I. N., Castiglione, V., Alkouri, R., Bertocchio, J. P., Inaoui, R., Daudon, M., Dousseaux, M.-P., Cavalier, E., Pieroni, L., & Izzedine, H. (2022). How useful is an oral calcium load test for diagnosing recurrent calcium stone formers? Urolithiasis. doi:10.1007/s00240-022-01355-w

Pottel, H., Cavalier, E., Björk, J., Nyman, U., Grubb, A., Ebert, N., Schaeffner, E., Eriksen, B. O., Melsom, T., Lamb, E. J., Mariat, C., Dubourg, L., Hansson, M., Littmann, K., Sundin, P.-O., Åkesson, A., Larsson, A., Rule, A., & Delanaye, P. (03 August 2022). Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function. Clinical Kidney Journal, 15 (12), 2258-2265. doi:10.1093/ckj/sfac182

Demeuse, J., Grifnee, E., Massonnet, P., Huyghebaert, L., Peeters, S., Le Goff, C., & Cavalier, E. (August 2022). Mass spectrometry evaluation of type I collagen in-situ digestion in biological matrices [Poster presentation]. IMSC 2022, Maastricht, Netherlands.

Huyghebaert, L., Demeuse, J., Grifnee, E., Massonnet, P., Farre Segura, J., Peeters, S., Le Goff, C., & Cavalier, E. (August 2022). Simultaneous detection and quantification of angiotensin I, II, 1-7 and 1-9 by LC-MS/MS in human plasma [Poster presentation]. International Mass Spectrometry Conference (IMSC) 2022, Maastricht, Netherlands.

Massonnet, P., Peeters, S., Grifnee, E., Demeuse, J., Huyghebaert, L., Farre Segura, J., Delanaye, P., Le Goff, C., & Cavalier, E. (August 2022). Iohexol quantitation and possible degradation kinetics in human urine using mass spectrometry coupled to liquid chromatography (LC) [Poster presentation]. International Mass Spectrometry Conference (IMSC) 2022, Maastricht, Netherlands.

De Niet, S., Trémège, M., Coffiner, M., Rousseau, A.-F., CALMES, D., Frix, A.-N., GESTER, F., Delvaux, M., DIVE, A.-F., GUGLIELMI, E., Henket, M., Staderoli, A., Maesen, D., Louis, R., Guiot, J., & Cavalier, E. (26 July 2022). Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 14 (15), 3048. doi:10.3390/nu14153048

Joris, M., Pincemail, J., COLSON, C., JORIS, J., CALMES, D., Cavalier, E., Misset, B., Guiot, J., MINGUET, G., & Rousseau, A.-F. (25 July 2022). Exercise Limitation after Critical Versus Mild COVID-19 Infection: A Metabolic Perspective. Journal of Clinical Medicine, 11 (15), 4322. doi:10.3390/jcm11154322

Ledeck, J., Dufour, P., Brutinel, F., Egyptien, S., CAVALIER, E., & Ponthier, J. (28 June 2022). Comparison of combined thickness of the uterus and the placenta between 2 breeds of mares and their potential relationship with estrogens during normal pregnancy [Poster presentation]. International Congress on Animal Reproduction 2020+2, Bologne, Italy.

Résimont, G., VRANKEN, L., Pottel, H., JOURET, F., KRZESINSKI, J.-M., CAVALIER, E., & DELANAYE, P. (27 June 2022). Estimating urine albumin to creatinine ratio from protein to creatinine ratio using same day measurement: validation of equations. Clinical Chemistry and Laboratory Medicine, 60 (7), 1064-1072. doi:10.1515/cclm-2022-0049

BOUQUEGNEAU, A., MALAISE, O., SEIDEL, L., BONVOISIN, C., WEEKERS, L., JOURET, F., CAVALIER, E., & DELANAYE, P. (May 2022). Bone Mineral Density, Bone Micro-Architecture Evolution After Kidney Transplantation: A Prospective Cohort Study. Nephrology Dialysis Transplantation, 37 (Supplement_3). doi:10.1093/ndt/gfac073.006

DELANAYE, P., Bjork, J., Vidal-Petiot, E., Ebert, N., Odvar Eriksen, B., Dubourg, L., Grubb, A., Hansson, M., Lamb, E., Littman, K., Mariat, C., Melsom, T., Schaeffner, E., Sundin, P.-O., Bokenkamp, A., Berg, U., Asling-Monemi, K., Åkesson, A., Larsson, A., ... Flamant, M. (May 2022). Performance of Creatinine-Based Equations to Estimate Glomerular Filtration Rate in White and Black Subjects From Europe, Brazil and Africa. Nephrology Dialysis Transplantation, 37 (Supplement_3), 385. doi:10.1093/ndt/gfac069.018

LE GOFF, C., LADANG, A., GOTHOT, A., & CAVALIER, E. (May 2022). Les marqueurs biologiques de l’inflammation : faisons le point. Revue Médicale de Liège, 77 (5-6), 258-264.

Demeuse, J., Calaprice, C., Huyghebaert, L., Rechchad, M., CAVALIER, E., & LE GOFF, C. (April 2022). Validation of an ultra-sensitive method for the quantification of melatonin in human saliva [Poster presentation]. EuroMedLab 2021 Munich, Munich, Germany.

ROUSSEAU, A.-F., schmitz, S., CAVALIER, E., Misset, B., & BOEMER, F. (07 March 2022). Altered Serum Acylcarnitines Profile after a Prolonged Stay in Intensive Care. Nutrients, 14 (5), 1122. doi:10.3390/nu14051122

LE GOFF, C., Gergelé, L., SEIDEL, L., CAVALIER, E., & KAUX, J.-F. (March 2022). Mountain Ultra-Marathon (UTMB) Impact on Usual and Emerging Cardiac Biomarkers. Frontiers in Cardiovascular Medicine, 9, 856223. doi:10.3389/fcvm.2022.856223

LE GOFF, C., Viallon, M., KAUX, J.-F., Andonian, P., Moulin, K., Seidel, L., Giardini, G., Gergelé, L., Croisille, P., CAVALIER, E., & Millet, G. P. (March 2022). Kinetics of Cardiac Remodeling and Fibrosis Biomarkers During an Extreme Mountain Ultramarathon. Frontiers in Cardiovascular Medicine, 9, 790551. doi:10.3389/fcvm.2022.790551

Cambier, M., Henket, M., Frix, A.-N., Gofflot, S., THYS, M., Tomasetti, S., Peired, A., Struman, I., Rousseau, A.-F., Misset, B., Darcis, G., Moutschen, M., Louis, R., Njock, M.-S., Cavalier, E., & Guiot, J. (2022). Increased KL-6 levels in moderate to severe COVID-19 infection. PLoS ONE, 17 (11), 0273107. doi:10.1371/journal.pone.0273107

Delanaye, P., & Cavalier, E. (2022). Impact des nouvelles équations EKFC et CKD-EPI (sans facteur ethnique) sur la prévalence de la maladie rénale chronique. Néphrologie et Thérapeutique, 18 (5), 20.

DELANAYE, P., Cavalier, E., & Bouquegneau, A. (2022). The ideal drug dosage adaptation through estimated glomerular filtration rate in obese patients? Measuring GFR is the key. British Journal of Clinical Pharmacology. doi:10.1111/bcp.15255

DELANAYE, P., DUBOIS, B., CAVALIER, E., & JOURET, F. (2022). Vignette diagnostique de l’étudiant : approche diagnostique de la maladie rénale chronique. Revue Médicale de Liège, 7 (4), 249-252.

Frisee, V., Rigaux, G., Dufour, P., Barbato, O., Brutinel, F., Egyptien, S., Bossaert, P., Deleuze, S., Cavalier, E., & Ponthier, J. (January 2022). American Bison (Bison bison) reproductive endocrinology: serum Pregnancy Associated Glycoproteins (PAG), Progesterone, Estrone and Estrone-Sulfate in non pregnant animals and during gestation. Domestic Animal Endocrinology, 78, 106684. doi:10.1016/j.domaniend.2021.106684

Ladang, A., Kovacs, S., Lengele, L., Locquet, M., Reginster, J.-Y., Bruyère, O., & Cavalier, E. (2022). Neurofilament light chain concentration in an aging population. Aging Clinical and Experimental Research, 34 (2), 331-339. doi:10.1007/s40520-021-02054-z

LADANG, A., KOVACS, S., Lengele, L., Reginster, J.-Y., Bruyère, O., & Cavalier, E. (2022). Neurofilament-light chains (NF-L), a biomarker of neuronal damage, is increased in sarcopenic patients: results of the sarcophage study. Osteoporosis International, 32 (Suppl 1), 53.

Laurent, M. R., Goemaere, S., Verroken, C., Bergmann, P., Body, J.-J., Bruyère, O., Cavalier, E., Rozenberg, S., Lapauw, B., & Gielen, E. (2022). Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club. Frontiers in Endocrinology, 13, 908727. doi:10.3389/fendo.2022.908727

Résimont, G., Cavalier, E., Radermecker, R., & Delanaye, P. (2022). Albuminuria in diabetic patients: How to measure it?-a narrative review. Journal of Laboratory and Precision Medicine, 7, 4-4. doi:10.21037/jlpm-21-58

ROUSSEAU, A.-F., DEROISY, R., LECART, M.-P., MASSENET, V., SARLET, N., Misset, B., CAVALIER, E., & KAUX, J.-F. (2022). Bone health in survivors of a prolonged ICU stay. Aging Clinical and Experimental Research, 34 (S1), 332.

Shadouh, C., Bruyère, O., & Cavalier, E. (2022). Performance of three screening questionnaires to assess vitamin D status in the general population. Osteoporosis International, 32 (Suppl 1), 305.

Pincemail, J., CAVALIER, E., CHARLIER, C., CHERAMY-BIEN, J.-P., BREVERS, E., Courtois, A., FADEUR, M., Meziane, S., LE GOFF, C., Misset, B., Albert, A., Defraigne, J.-O., & ROUSSEAU, A.-F. (December 2021). Oxidative Stress Status in COVID-19 Patients Hospitalized in Intensive Care Unit for Severe Pneumonia. A Pilot Study. Free Radical Biology and Medicine, 177, 119-S120. doi:10.1016/j.freeradbiomed.2021.08.192

Pincemail, J., ROUSSEAU, A.-F., KAUX, J.-F., CHERAMY-BIEN, J.-P., Bruyere, C., PRICK, J., Stern, D., Mouna-Messaouda, K., MAERTENS DE NOORDHOUT, B., Albert, A., Defraigne, J.-O., Misset, B., CAVALIER, E., CHARLIER, C., & Meziane, S. (December 2021). Oxidative Stress Status and its correlation with Redox Status as Measured By An Electrochemical (PAOT®) Methodology: A Pilot Study in Critical COVID-19 Pneumonia Survivors. Free Radical Biology and Medicine, 177, 120. doi:10.1016/j.freeradbiomed.2021.08.193

Le Goff, C., Cavalier, E., & Kaux, J.-F. (November 2021). Le point sur le sport intense et les marqueurs cardiaques. Vaisseaux, Coeur, Poumons, 26 (6), 18-21.

Chevalley, T., Brandi, M., Cavalier, E., Harvey, N., Iolascon, G., Cooper, C., Hannouche, D., Kaux, J.-F., Kurth, A., Maggi, S., Maier, G., Papavasiliou, K., Al-Daghri, N., Sosa-Henriquez, M., Suhm, N., Tarantino, U., Reginster, J.-Y., & Rizzoli, R. (October 2021). How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture? Osteoporosis International, 32 (10), 1921-1935. doi:10.1007/s00198-021-05957-9

Parotte, M. C., VALDES SOCIN, H. G., & CAVALIER, E. (01 October 2021). Hypercalcémie aggravée par l’administration de vitamine D chez un patient adulte révélant une mutation hétérozygote composite CYP24A1 : réponse et traitement à long terme par rifampicine. Annales d'Endocrinologie, 82, 311.

Demeuse, J., Calaprice, C., LE GOFF, C., & CAVALIER, E. (26 May 2021). TROUBLESHOOTING: Development of a LC-MS/MS method for trace level analysis of salivary melatonin [Poster presentation]. CIRM DAY 2021, Liège, Belgium.

Laurent, M., De Schepper, J., Trouet, D., Godefroid, N., Boros, E., Heinrichs, C., Bravenboer, B., Velkeniers, B., Lammens, J., Harvengt, P., Cavalier, E., Kaux, J.-F., LOMBET, J., De Waele, K., Verroken, C., van Hoeck, K., Mortier, G., Levtchenko, E., & Vande Walle, J. (March 2021). Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium. Frontiers in Endocrinology, 12, 641543. doi:10.3389/fendo.2021.641543

PINCEMAIL, J., CAVALIER, E., CHARLIER, C., CHERAMY-BIEN, J.-P., BREVERS, E., COURTOIS, A., FADEUR, M., Meziane, S., LE GOFF, C., Misset, B., Albert, A., DEFRAIGNE, J., & ROUSSEAU, A.-F. (07 February 2021). Oxidative Stress Status in COVID-19 Patients Hospitalized in Intensive Care Unit for Severe Pneumonia. A Pilot Study. Antioxidants, 10 (257). doi:10.3390/antiox10020257

HUART, J., BOUQUEGNEAU, A., Lutteri, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., BOVY, C., Krzesinski, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., Mariat, C., CAVALIER, E., Burtey, S., Jouret, F., & DELANAYE, P. (23 January 2021). Proteinuria in COVID‑19: prevalence, characterization and prognostic role. Journal of Nephrology, 34 (3), 355-364. doi:10.1007/s40620-020-00931-w

Annweiler, C., BRUYERE, O., CAVALIER, E., young, J., & Souberbielle, C. (January 2021). Assurer un statut satisfaisant en vitamine D dans la population générale est particulièrement important dans le contexte de la Covid-19. Revue du Praticien, 71 (1), 7-11.

BOUQUEGNEAU, A., HUART, J., LUTTERI, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., ROUSSEAU, A.-F., BOVY, C., KRZESINSKI, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., DARCIS, G., CAVALIER, E., JOURET, F., & DELANAYE, P. (2021). Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Journal of Nephrology, 34 (4), 967-969. doi:10.1007/s40620-021-01075-1

DELANAYE, P., & CAVALIER, E. (2021). Arguments for an age-adapted definition of chronic kidney disease. Portuguese Journal of nephrology and hypertension, 35 (4), 261-262.

DELANAYE, P., Melsom, T., CAVALIER, E., Pottel, H., Eriksen, B., & Dubourg, L. (2021). Iohexol plasma clearance: impact of weighing the syringe. Kidney International Reports, 6 (9), 2478-2480. doi:10.1016/j.ekir.2021.05.038

DELANAYE, P., Vidal-Petiot, Stehlé, T., Dubourg, Gaillard, F., Sterner, G., White, C., Lemoine, S., Audard, V., Prié, D., CAVALIER, E., Courbebaisse, M., Pottel, H., & Flamant, M. (2021). Comparison of plasma clearance with early-compartment correction equations and urinary clearance in high GFR ranges. Kidney International Reports, 6 (6), 1622-1628. doi:10.1016/j.ekir.2021.03.886

Dufour, P., Courtois, J., SEYNAEVE, Y., PEETERS, S., LE GOFF, C., CAVALIER, E., & Ponthier, J. (2021). Development and validation of a liquid chromatography coupled to mass spectrometer (LC-MS) method for the simultaneous quantification of estrone-3-sulfate, progesterone, estrone and estradiol in serum of mares and American bisons. Research in Veterinary Science, 136, 343-350. doi:10.1016/j.rvsc.2021.03.014

Résimont, G., VRANKEN, L., CAVALIER, E., & DELANAYE, P. (2021). Estimation d’un ratio Albumine/Créatinine urinaire à partir d’un ratio Protéine/Créatinine urinaire au départ de mesures réalisées sur un même échantillon : validation d’équations [Paper presentation]. VI congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Toulouse, France.

Sanchez Rodriguez, M. D. C., Locquet, M., Bruyère, O., Lengele, L., CAVALIER, E., Reginster, J.-Y., & Beaudart, C. (2021). Prediction of 5-year mortality risk by malnutrition according to the GLIM format using seven pragmatic approaches to define the criterion of loss of muscle mass. Clinical Nutrition, 40 (4), 2188-2199. doi:10.1016/j.clnu.2020.09.047

Zhang, Z., Huang, C., Cao, Y., Mu, R., Zhang, M. C., Xing, D., Fan, D., Ding, Y., Guo, J., Hou, Y., Jianhao, L., Veronese, N., Reginster, J.-Y., Bruyère, O., Cavalier, E., & Zhang, H. (2021). 2021 revised algorithm for the management of knee osteoarthritis-the Chinese viewpoint. Aging Clinical and Experimental Research, 33 (8), 2141-2147. doi:10.1007/s40520-021-01906-y

Schoneveld, L., LUKAS, P., CAVALIER, E., & GADISSEUR, R. (20 November 2020). CA19.9 assays provide clinically different results for the patients [Poster presentation]. 2020 Annual Royal Belgian Society of Laboratory Medicine Meeting.

Courbebaisse, M., & CAVALIER, E. (2020). Vitamin D in 2020: An Old Pro-Hormone with Potential Effects beyond Mineral Metabolism. Nutrients. doi:10.3390/nu12113378

DELANNOY, P., VRANKEN, L., CAVALIER, E., & VALDES SOCIN, H. G. (2020). Carence en vitamine B12 : diagnostic et prise en charge. Tempo Médical, 24-28.

Cavalier, E., & Le Goff, C. (May 2020). La chromatographie liquide couplée à un spectromètre de masse en tandem (LC-MS/MS) : une révolution dans le laboratoire de chimie clinique. Revue Médicale de Liège, 75 (5-6), 457-459.

LE GOFF, C., Farre Segura, J., Dufour, P., KAUX, J.-F., & CAVALIER, E. (May 2020). Intense sport practices and cardiac biomarkers. Clinical Biochemistry, 79, 1-8. doi:10.1016/j.clinbiochem.2020.02.008

LE GOFF, C.* , Farre Segura, J.* , STOJKOVIC, V., Dufour, P., PEETERS, S., Courtois, J., NIZET, A., De Vos, N., & CAVALIER, E. (2020). The pathway through LC-MS method development: in-house or ready-to-use kit-based methods? Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2019-0916
* These authors have contributed equally to this work.

DELANAYE, P., Dubourg, L., Flamant, M., Yayo, E., Bukabau, J., Vidal-Petiot, E., Lemoine, S., CAVALIER, E., Schaeffner, E., Monnet, D., Sumaili, E., Ebert, N., & Pottel, H. (2020). Comparison of early-compartment correction equations for GFR measurements. Kidney International Reports, 5 (7), 1079-1081. doi:10.1016/j.ekir.2020.04.015

Lorentzon, M., Branco, J., Brandi, M. L., Bruyère, O., Chapurlat, R., Cooper, C., Cortet, B., Diez-Perez, A., Ferrari, S., Gasparik, A., Herrman, M., Jorgensen, N. R., Kanis, J. A., Kaufman, J. M., Laslop, A., Locquet, M., Matijevic, R., McCloskey, E. V., Minisola, S., ... CAVALIER, E. (2020). Clinical application of bone turnover markers in postmenopausal osteoporosis. Osteoporosis International, 31 (S1), 65-66.

Rozenberg, S., Bruyère, O., Bergmann, P., Cavalier, E., Gielen, E., Goemaere, S., Kaufman, J. M., Lapauw, B., Laurent, M. R., De Schepper, J., & Body, J. J. (2020). How to manage osteoporosis before the age of 50. Maturitas, 138, 14-25. doi:10.1016/j.maturitas.2020.05.004

Sanchez Rodriguez, M. D. C., Bergmann, P., Body, J., CAVALIER, E., Gielen, E., Goemaere, S., Lapauw, B., Laurent, M., Rozenberg, S., Honvo, G., BEAUDART, C., & BRUYERE, O. (2020). The Belgian Bone Club 2020 Guidelines for the management of osteoporosis in postmenopausal women. Osteoporosis International, 31 (S1), 83 and 532-533.

Sanchez Rodriguez, M. D. C., Locquet, M., Reginster, J.-Y., Cavalier, E., Bruyère, O., & Beaudart, C. (2020). Mortality in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge study. Journal of Cachexia, Sarcopenia and Muscle, 11 (5), 1200-1211. doi:10.1002/jcsm.12574

Sanchez Rodriguez, M. D. C., Locquet, M., Reginster, J.-Y., CAVALIER, E., Bruyère, O., & Beaudart, C. (2020). Diagnosis of malnutrition using GLIM criteria : validity of 7 pragmatic approaches which do not require the measurement of muscle mass. Osteoporosis International, 31 (S1), 618.

De Maré, A., Verhulst, A., CAVALIER, E., DELANAYE, P., Behets, G. J., Meijers, B., Kuypers, D., D'Haese, P., & Evenepoel, P. (December 2019). Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease. Journal of Clinical Medicine, 8 (12), 2027. doi:10.3390/jcm8122027

VRANKEN, L., BERTHOLET, C., LUKAS, P., & CAVALIER, E. (15 November 2019). Comparison of two automated assays for the determination of cobalaminin serum [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

VRANKEN, L., FONTAINE, C., LUKAS, P., & CAVALIER, E. (15 November 2019). Unexpected high levels of Cobalamin (Vitamin B12). Is PEG treatment useful? [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

VRANKEN, L., FONTAINE, C., VALDES SOCIN, H. G., LUKAS, P., LE GOFF, C., Huyghebaert, L., & CAVALIER, E. (15 November 2019). Impact of Metformin on vitamin B12 status [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

VRANKEN, L., PIELTAIN, C., & CAVALIER, E. (15 November 2019). Evaluation of neonatal bilirubin method on GEM 5000 blood gas analyzer [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine 2019.

DELANAYE, P., VRANKEN, L., Pottel, H., & CAVALIER, E. (2019). Impact du choix de l’équation basée sur la créatinine sur la classification de la maladie rénale chronique dans une base de données de laboratoire. Néphrologie et Thérapeutique.

DELANAYE, P., VRANKEN, L., Schoneveld, L., LAMBERMONT, B., & CAVALIER, E. (2019). Prévalence de l’atteinte rénale aigue chez le patient hospitalisé en fonction du critère de variation de la créatinine utilisée. Néphrologie et Thérapeutique.

Nyssen, L., Fillet, M., CAVALIER, E., & Servais, A.-C. (26 September 2019). Separation of Intact Parathyroid Hormone and Variants Using a Highly Sensitive Sheathless CE-ESI-MS/MS Method [Poster presentation]. MSACL 2019 EU.

CASTIGLIONE, V., Pottel, H., Lieske, J. C., LUKAS, P., CAVALIER, E., DELANAYE, P., & Rule, A. (2019). Evaluation of inactive Matrix-Gla-Protein (MGP) as a biomarker for incident and recurrent kidney stones. Journal of Nephrology. doi:10.1007/s40620-019-00623-0

GADISSEUR, R., HAMIDOU, T., Cavalier, E. (Other coll.), Courtois, J. (Other coll.), vanderbrempt, X. (Other coll.), Tollenaere, S. (Other coll.), Maizoumbou (Other coll.), Jacquier (Other coll.), & Laouali (Other coll.). (03 June 2019). Sensitization profile of cricket food-allergic or cricket tolerant patients in an entomophagous population in Niamey, Niger. Allergy, 74.

GADISSEUR, R., LUKAS, P., & Cavalier, E. (03 June 2019). Phleum pratense may be taken as a marker allergen for Gx3 grass mix. Allergy, 74 (106), 101-331.

GADISSEUR, R., LUKAS, P., & Cavalier, E. (03 June 2019). Betula verrucosa may be taken as a marker allergen for Tx5 tree mix. Allergy, 74 (106), 130-331.

BERTHOLET, C., Lamtiri-Laarif, M., VRANKEN, L., GADISSEUR, R., DELCOUR, S., & CAVALIER, E. (May 2019). Verification of the reference intervals proposed by Abbott on Alinity ci in a population of healthy subjects from Liege, Belgium [Poster presentation]. Euromedlab IFCC.

DE VOEGHT, A., Godon, E., Chachati, A., CAVALIER, E., & Buysschaert, B. (2019). HYPERCALCÉMIE SUR INTOXICATION À LA VITAMINE D : VIGNETTE CLINIQUE ET REVUE DE LA LITTÉRATURE. Louvain Medical.

LADANG, A., BERTHOLET, C., VRANKEN, L., & CAVALIER, E. (May 2019). GLOBAL STRATEGY OF IMPLEMENTATION OF CALIPER PEDIATRIC REFERENCE VALUES IN A BELGIAN INSTITUTE [Poster presentation]. Euromedlab 2019.

LADANG, A., ROUSSELLE, O., BEKAERT, A.-C., KOVACS, S., & CAVALIER, E. (May 2019). PEDIATRIC REFERENCE INTERVALS FOR BONE ALKALINE PHOSPHATASE ON LIAISON° XL [Poster presentation]. Euromedlab 2019.

LADANG, A., ROUSSELLE, O., Huyghebaert, L., BEKAERT, A.-C., KOVACS, S., LE GOFF, C., & CAVALIER, E. (May 2019). EVALUATION OF PARATHORMONE AND 25-HYDROXYVITAMIN D STATUS IN A LARGE [Poster presentation]. Euromedlab 2019.

LADANG, A., ROUSSELLE, O., Huyghebaert, L., BEKAERT, A.-C., KOVACS, S., LE GOFF, C., & CAVALIER, E. (May 2019). 24,25(OH)2D AS A MARKER OF VITAMIN D DEFICIENCY IN CHILDREN: A RETROSPECTIVE [Poster presentation]. Euromedlab 2019.

LADANG, A., Seynaeve, Y., & CAVALIER, E. (May 2019). DIAGNOSTIC POTENTIAL OF MIRNAS IN PARATHYROID CARCINOMAS [Poster presentation]. Euromedlab 2019.

Senterre, Y., Fombellida, K., CAVALIER, E., PAQUOT, N., & DELANAYE, P. (May 2019). Are variations of glycated hemoglobin given by the freestyle device accurate? [Poster presentation]. XXIII IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, Barcelone, Spain.

VALDES SOCIN, H. G., VRANKEN, L., Schoneveld, L., DELANNOY, P., Le Goff, C., Beckers, A., & CAVALIER, E. (2019). Vitamin B12 deficiency prevalence and associated biomarkers in type 2 Diabetes (T2DM) treated with metformin : biochemical assessment in a series of 106 patients. In Endocrine Abstracts - ECE 2019.

VRANKEN, L., FONTAINE, C., LUKAS, P., & CAVALIER, E. (May 2019). Unexpected high levels of Cobalamin(Vitamin B12). Is PEG treatment a solution? [Poster presentation]. 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Barcelona 2019.

VRANKEN, L., FONTAINE, C., LUKAS, P., LE GOFF, C., Huyghebaert, L., CAVALIER, E., & VALDES SOCIN, H. G. (May 2019). Evaluation of Metformin impact on vitamin B12 status [Poster presentation]. 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine “EuroMedLab” Barcelona 2019, Barcelone, Spain.

LADANG, A., Beaudart, C., Locquet, M., Reginster, J.-Y., Bruyère, O., & CAVALIER, E. (April 2019). Risk-fracture prediction in elderly people based on a microRNA panel [Poster presentation]. IOF-WHO osteoporosis congress.

Le Goff, C., Lennartz, L., VRANKEN, L., Kaux, J.-F., & Cavalier, E. (February 2019). Comparison of cardiac biomarker dynamics in marathon, semimarathon and untrained runners: what is the impact on results interpretation? Journal of Laboratory and Precision Medicine, 4 (6), 10. doi:10.21037/jlpm.2019.01.04

DELANAYE, P., Bataille, S., Quinonez, K., Buckinx, F., Warling, X., KRZESINSKI, J.-M., Pottel, H., Burtey, S., Bruyère, O., & CAVALIER, E. (25 January 2019). Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis. Journal of Renal Nutrition, 29 (6), 511-520. doi:10.1053/j.jrn.2018.11.010

BOUQUEGNEAU, A., Evenepoel, P., PAQUOT, F., MALAISE, O., CAVALIER, E., & DELANAYE, P. (2019). Sclerostin within the chronic kidney disease spectrum. Clinica Chimica Acta, 502, 84-90. doi:10.1016/j.cca.2019.12.008

Bukabau, J., Yayo, E., Gnionsahé, A., Monnet, D., Pottel, H., CAVALIER, E., Nkodila, A., Makula, Mokoli, V., Lepira, F., Nseka, M., KRZESINSKI, J.-M., Sumaili, E., & DELANAYE, P. (2019). Performance of creatinine- or cystatin C-based equations to estimate glomerular filtration rate in sub-Saharan African populations. Kidney International, 95 (5), 1181-1189. doi:10.1016/j.kint.2018.11.045

Delanaye, P., Bataille, P., Quinonez, K., Buckinx, F., Warling, X., KRZESINSKI, J.-M., Pottel, H., Burtey, S., Bruyère, O., & CAVALIER, E. (2019). Myostatin and insulin growth factor 1 are biomarkers of muscle strength, muscle mass, and mortality in hemodialysis patients. Osteoporosis International, 30 (S2), 270.

masson, G., VRANKEN, L., KRZESINSKI, J.-M., Pottel, H., CAVALIER, E., & DELANAYE, P. (2019). Impact of the creatinine-based equations used on the chronic kidney disease classification in a large laboratory database. Nephrology Dialysis Transplantation.

Van Egroo, M., Narbutas, J., Chylinski, D., Villar Gonzalez, P., Ghaemmaghami Tabrizi, P., Muto, V., Schmidt, C., Gaggioni, G., Besson, G., Pepin, X., Tezel, E., Marzoli, D., Le Goff, C., Cavalier, E., Luxen, A., Salmon, E., Maquet, P., Bahri, M. A., Phillips, C., ... Vandewalle, G. (2019). Preserved wake-dependent cortical excitability dynamics predict cognitive fitness beyond age-related brain alterations. Communications Biology, 2, 449. doi:10.1038/s42003-019-0693-y

Castiglione, V., Sacre, P.-Y., Cavalier, E., Hubert, P., GADISSEUR, R., & Ziemons, E. (16 November 2018). Raman chemical imaging, a new tool in kidney stone structure analysis: Case-study and comparison to Fourier Transform Infrared spectroscopy [Poster presentation]. Joint Annual Meeting of the Royal Belgian Society of Laboratory Medicine and the Belgian Thyroid Club.

CASTIGLIONE, V., CAVALIER, E., & GADISSEUR, R. (2018). Clinical data on rare Sulfamethoxazole crystalluria assessed by Fourier Transform Infrared Spectrophotometry. Data in Brief. doi:10.1016/j.dib.2018.11.006

Résimont, G., GADISSEUR, R., LUTTERI, L., KRZESINSKI, J.-M., CAVALIER, E., & DELANAYE, P. (October 2018). Comment j'explore...Une protéinurie. Revue Médicale de Liège, 73 (10), 519-525.

GADISSEUR, R., MUSSO, G., Cavalier, E., & VRANKEN, L. (Other coll.). (28 September 2018). Validation of 24 blood gas analyzers, GEM 5000 Premier [Poster presentation]. AACC POCT, washington, United States.

Castiglione, V., Sacre, P.-Y., CAVALIER, E., Hubert, P., GADISSEUR, R., & Ziemons, E. (03 August 2018). Raman Chemical Imaging, a new tool in kidney stone structure analysis: Case-study and comparison to Fourier Transform Infrared spectroscopy. PLoS ONE, 13 (8), 0201460. doi:10.1371/journal.pone.0201460

Schmidt, C., Xhrouet, M., Hamacher, M., Delloye, E., Le Goff, C., Cavalier, E., Collette, F., & Vandewalle, G. (June 2018). Light exposure via a head-mounted device suppresses melatonin and improves vigilant attention without affecting cortisol and comfort. PsyCh Journal, 7. doi:10.1002/pchj.215

VALDES SOCIN, H. G., BETEA, D., Daly, A., DELANAYE, P., Souberbielle, J.-C., Beckers, A., & CAVALIER, E. (May 2018). hCG as a diagnostic test to differentiate between parathyroid carcinoma, primary benign hyperparathyroidism and secondary hyperparathyroidism [Poster presentation]. 20th European Congress of Endocrinology.

Fabregat Cabello, N., Pitarch-Motellón, J., LE GOFF, C., & Cavalier, E. (20 April 2018). Recertification of 25-hydroxyvitamin D standards by Isotope Pattern Deconvolution (IPD) [Paper presentation]. Benelux Association of Stable Isotopes, (BASIS), Liège, Belgium.

Bataille, S., QUINONEZ, K., Buckinx, F., Warling, X., KRZESINSKI, J.-M., Pottel, H., Burtey, S., Bruyère, O., CAVALIER, E., & DELANAYE, P. (2018). La myostatine et l’IGF1 sont de bons biomarqueurs de la force musculaire chez les patients hémodialysés chroniques. Néphrologie et Thérapeutique, 14 (5), 4.

Bukabau, J., Gnionsahé, A., Monnet, D., Pottel, H., CAVALIER, E., Makulo, J., Nseka, Sumaili, E., DELANAYE, P., & Yayo, E. (2018). Performance des équations basées sur la créatinine ou la cystatine C en Afrique sub-saharienne : intérêt de l’équation « Full Age Spectrum ». Néphrologie et Thérapeutique, 14 (5), 14.

Bukabau, J., Sumaili, E., CAVALIER, E., Pottel, H., Kifakiou, B., Nkodila, A., Makulo, J., Mokoli, V., Zinga, C., Longo, A., Engole, Y., Nlandu, Y., Lepira, F., Nseka, N., KRZESINSKI, J.-M., & DELANAYE, P. (2018). Performance of glomerular filtration rate estimation equations in Congolese healthy adults: the inopportunity of the ethnic correction. PLoS ONE, 13 (3), 0193384. doi:10.1371/journal.pone.0193384

Castiglione, V., CAVALIER, E., & GADISSEUR, R. (2018). Case report: Uncommon Sulfamethoxazole Crystalluria. Clinical Biochemistry. doi:10.1016/j.clinbiochem.2018.05.009

De Niet, S., Coffiner, M., Da Silva, S., JANDRAIN, B., Souberbielle, J.-C., & Cavalier, E. (2018). A randomized study to compare a monthly to a daily administration of vitamin D3 supplementation. Nutrients, 10 (6). doi:10.3390/nu10060659

DELANAYE, P., Pottel, H., Flamant, M., Vidal-Petiot, E., Lemoine, S., CAVALIER, E., Schaeffner, E., Ebert, N., & Dubourg, L. (2018). Measurement of glomerular filtration rate by plasma iohexol clearance with different single-sample methods [Poster presentation]. LV Congress of ERA-EDTA, Copenhagen, Denmark.

Dinic, M., Maillard, N., DELANAYE, P., KRZESINSKI, J.-M., SAINT-REMY, A., CAVALIER, E., & Mariat, C. (2018). Association between matrix gla protein and aortic stiffness in kidney transplantation [Poster presentation]. LV Congress of ERA-EDTA, Copenhagen, Denmark.

Flamant, M., DELANAYE, P., Pottel, H., Vidal-Petiot, E., Lemoine, S., CAVALIER, E., Schaeffner, E., Ebert, N., & Dubourg, L. (2018). Mesure du débit de filtration glomérulaire par prélèvement plasmatique unique : impact des différentes modelisations mathématiques [Poster presentation]. III congrès de la Société francophone de néphrologie dialyse et transplantation, Lille, France.

PAQUOT, F., DELANAYE, P., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Maillard, N., Pottel, H., Evenepoel, P., & CAVALIER, E. (2018). Variations of sclerostin with other bone biomarkers over a one-year period in hemodialysis patients [letter to the editor]. Clinica Chimica Acta, 486, 183-184. doi:10.1016/j.cca.2018.08.003

Résimont, G., GADISSEUR, R., DUBOIS, B., KRZESINSKI, J.-M., CAVALIER, E., & DELANAYE, P. (2018). Bandelette urinaire positive pour une recherche de protéinurie : correspondance avec un résultat quantitatif sur échantillon [Poster presentation]. III congrès de la Société francophone de néphrologie dialyse et transplantation, Lille, France.

Yayo, E., Bukabau, J., Gnionsahé, A., Monnet, D., Pottel, H., CAVALIER, E., Sumaili, E., DELANAYE, P., & Nseka, N. (2018). Mesure du DFG en population africaine par la clairance plasmatique de l’iohexol : comparaison des méthodes à prélèvement unique et prélèvements multiples [Poster presentation]. III congrès de la Société francophone de néphrologie dialyse et transplantation, Lille, France.

VALDES SOCIN, H. G., BETEA, D., Daly, A., DELANAYE, P., souberbielle, J.-C., BECKERS, A., & CAVALIER, E. (December 2017). Paraneoplastic secretion in parathyroid carcinoma: serum hCG as a tumor marker. Acta Clinica Belgica, 72 (2), 5.

Castiglione, V., & CAVALIER, E. (24 November 2017). Oral calcium load test for recurrent calcium stone-formers [Paper presentation]. Joint National Symposium of the Belgian Lipid Club and the Royal Belgian Society of Laboratory Medicine 2017, Bruges, Belgium.

Castiglione, V., & CAVALIER, E. (24 November 2017). Oral calcium load test for recurrent calcium stone-formers [Poster presentation]. Joint National Symposium of the Belgian Lipid Club and the Royal Belgian Society of Laboratory Medicine 2017, Bruges, Belgium.

Courtois, J., BERTHOLET, C., Cavalier, E., Gillard, N., Tollenaere, S., Quinting, B., & GADISSEUR, R. (24 November 2017). Interest of 2D Immunoblot and mass spectrometry in the diagnosis of wheat allergy [Poster presentation]. Royal Belgian Society of Laboratory Medicine, Bruges, Belgium.

LADANG, A., VRANKEN, L., & CAVALIER, E. (November 2017). Pediatric reference intervals: Retrospective study for 8 common chemistry parameters on Cobas c6000 analyzer (Roche°) [Poster presentation]. meeting annuel RBSLM.

Fabregat Cabello, N., Farre Segura, J., Huyghebaert, L., PEETERS, S., LE GOFF, C., & Cavalier, E. (September 2017). A fast and simple method for simultaneous measurements of 25(OH)D, 24,25(OH)2D and the Vitamin D Metabolite Ratio (VMR) in serum samples by LC-MS/MS (powerpoint) [Paper presentation]. MSACL, Salzburg, Austria.

Le Goff, C., VRANKEN, L., Kaux, J.-F., & Cavalier, E. (September 2017). Comparison of cardiac biomarkers fluctuation in runners of marathons, semi-marathons and untrained runners. European Journal of Sports Medicine, 5 (Supplement 1), 16.

Courtois, J., BERTHOLET, C., Cavalier, E., Gillard, N., Quinting, B., & GADISSEUR, R. (18 June 2017). How immunoblotting and mass spectrometry can help to diagnose kiwi fruit allergy [Poster presentation]. European Academy of Allergy and Clinical Immunology, Helsinki, Finland.

LE GOFF, C., Fabregat Cabello, N., Huyghebaert, L., PEETERS, S., VROONEN, L., & CAVALIER, E. (13 June 2017). Validation of a 13 steroids panel with the Chromsystem kit by LC-MS/MS [Poster presentation]. Euromedlab IFCC, Athenes, Greece.

LE GOFF, C., Fabregat Cabello, N., Huyghebaert, L., PEETERS, S., VROONEN, L., & CAVALIER, E. (2017). Reference interval determination for serum and urine aldosterone for healthy Belgian population. Clinical Chemistry and Laboratory Medicine.

LE GOFF, C., Fabregat Cabello, N., Huyghebaert, L., PEETERS, S., VROONEN, L., & CAVALIER, E. (2017). Establishment of reference values for 6 six steroids in serum. Clinical Chemistry and Laboratory Medicine.

LE GOFF, C., Kaux, J.-F., Gergelé, L., Millet, G., Viallon, M., Croisille, P., & CAVALIER, E. (2017). Impact of an ultra-trail of 330 km on plasma levels. Clinical Chemistry and Laboratory Medicine.

LE GOFF, C., VRANKEN, L., van Nueten, J., Lennartz, L., & CAVALIER, E. (2017). Comparison of cardiac biomarker fluctuation in runners of marathons, semi-marathons and untrained runners. Clinical Chemistry and Laboratory Medicine.

Courtois, J., BERTHOLET, C., LUKAS, P., Cavalier, E., Gillard, N., Tollenaere, S., Quinting, B., & GADISSEUR, R. (26 April 2017). Allergie au froment : caractérisation de nouveaux allergènes par immunoblot 2D et spectrométrie de masse [Poster presentation]. Congrès Francophone d'Allergologie, Paris, France. doi:10.1016/j.reval.2017.02.052

Sturgeon, C. M., Sprague, S., Almond, A., Cavalier, E., Fraser, W. D., Algeciras-Schimnich, A., Singh, R., Souberbielle, J.-C., & Vesper, H. W. (April 2017). Perspective and priorities for improvement of parathyroid hormone (PTH) measurement - A view from the IFCC Working Group for PTH. Clinica Chimica Acta, 467, 42-47. doi:10.1016/j.cca.2016.10.016

Cavalier, E., LUKAS, P., BEKAERT, A.-C., CARLISI, I., Le Goff, C., DELANAYE, P., & Souberbielle, J.-C. (March 2017). Analytical and clinical validation of the new Abbot Architect 25(OH)D assay: fit for purpose? Clinical Chemistry and Laboratory Medicine, 55 (3), 378-384. doi:10.1515/cclm-2016-0566

Gregoire, E., Claisse, G., GUIOT, J., MORIMONT, P., KRZESINSKI, J.-M., Mariat, C., LAMBERMONT, B., CAVALIER, E., & DELANAYE, P. (13 January 2017). The added value of plasma or urinary NGAL concentrations in clinical practice [Poster presentation]. Reanimation 2017, Paris, France.

Bargnoux, A.-S., Pieroni, L., Cristol, J.-P., Kuster, N., DELANAYE, P., Carlier, M.-C., Fellahi, S., Boutten, A., Lombard, C., Gonzalez-Antuna, A., Delatour, V., & Cavalier, E. (2017). Multicenter Evaluation of Cystatin C Measurement after Assay Standardization. Clinical Chemistry, 63 (4), 833-841. doi:10.1373/clinchem.2016.264325

Bruyère, O., CAVALIER, E., & Reginster, J.-Y. (2017). Vitamin D and osteosarcopenia: an update from epidemiological studies. Current Opinion in Clinical Nutrition and Metabolic Care, 20 (6). doi:10.1097/MCO.0000000000000411

Bukabau, J., Sumaili, E., CAVALIER, E., Kayembe, P., Makulo, J., Mokoli, V., Kifakiou, B., Nkodila, A., Engole, Y., Lepira, F., Nseka, N., & DELANAYE, P. (2017). Performance des équations d’estimation du débit de filtration glomérulaire chez l’adulte sain en Afrique centrale (Congo Kinshasa) [Poster presentation]. Deuxième congrès de la Société francophone de néphrologie, dialyse et transplantation (SFNDT), Nice, France.

DELANAYE, P., Cavalier, E., & Pottel, H. (2017). Serum Creatinine: Not So Simple! Nephron journals, 136 (4), 302-308. doi:10.1159/000469669

DELANAYE, P., QUINONEZ, K., Buckinx, F., Bruyère, O., & CAVALIER, E. (2017). Intérêt de nouveaux marqueurs biologiques dans l’évaluation de la sarcopénie en dialyse. Néphrologie et Thérapeutique, 13 (5), 269.

DELANAYE, P., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Maillard, N., Pottel, H., & CAVALIER, E. (2017). Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients. Scientific Reports, 7 (1), 12623. doi:10.1038/s41598-017-12808-3

Dinic, M., Maillard, N., DELANAYE, P., KRZESINSKI, J.-M., SAINT-REMY, A., CAVALIER, E., & Mariat, C. (2017). Association entre les taux circulants de matrix-gla protein et rigidité artérielle en transplantation rénale. Néphrologie et Thérapeutique, 13 (5), 309.

Ebert, N., Schaeffner, E., Pottel, H., CAVALIER, E., Dubourg, L., Flamant, M., & DELANAYE, P. (2017). Measuring Plasma Clearance for Exact Assessment of GFR: Multi versus Single Sampling [Poster presentation]. Renal Week, New Orleans, United States - Louisiana.

Flamant, M., Vidal-Petiot, E., Dubourg, L., Ebert, N., Lemoine, S., Schaeffner, E., Pottel, H., Cavalier, E., & DELANAYE, P. (2017). Mesure du débit de filtration glomérulaire par clairance plasmatique : comparaison d’une procédure à prélèvements multiples et à prélèvement unique [Poster presentation]. Deuxième congrès de la Société francophone de néphrologie, dialyse et transplantation (SFNDT), Nice, France.

Fusaro, M., Gallieni, M., Rizzo, M., Stucchi, A., DELANAYE, P., CAVALIER, E., Moyses, R., Jorgetti, V., Iervasi, G., Giannini, S., Fabris, F., Aghi, A., Sella, S., Galli, F., Viola, V., & Plebani, M. (2017). Vitamin K plasma levels determination in human health. Clinical Chemistry and Laboratory Medicine, 55 (6), 789-799. doi:10.1515/cclm-2016-0783

Herrmann, M., Farrell, C.-J. L., Pusceddu, I., Fabregat Cabello, N., & Cavalier, E. (2017). Assessment of vitamin D status - a changing landscape. Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2016-0264

LADANG, A., VRANKEN, L., LUYCKX, F., LEBRETHON, M.-C., & CAVALIER, E. (2017). Etude rétrospective du bilan thyroïdien: définition de valeurs de référence pédiatriques. Revue Médicale de Liège.

Le Goff, C., Huyghebaert, L., Peeters, S., Vroonen, L., & Cavalier, E. (2017). Establishment of reference values for 6 six steroids in serum by LC-MS/MS [Poster presentation]. Mass Spectrometry and Advances in Clinical Lab, Salzburg, Austria.

Libon, F., COURTOIS, J., Le Goff, C., LUKAS, P., Fabregat Cabello, N., SEIDEL, L., Cavalier, E., & Nikkels, A. (2017). Effect of Body Site and Surface on Vitamin D and 25-Hydroxyvitamin D Production after a Single Narrowband UVB Exposure. Journal of Investigative Dermatology, 137 (6), 1391-1393. doi:10.1016/j.jid.2017.01.032

Maillard, N., Warling, X., Moonen, M., Smelten, N., JOURET, F., KRZESINSKI, J.-M., Pottel, H., CAVALIER, E., & DELANAYE, P. (2017). Les pentes d’évolution des CTX, de la phosphatase alkaline osseuse et du P1NP sont associées à celles de la PTH en hémodialyse chronique [Poster presentation]. Deuxième congrès de la Société francophone de néphrologie, dialyse et transplantation (SFNDT), Nice, France.

Piéroni, L., Bargnoux, A., Cristol, J., CAVALIER, E., & DELANAYE, P. (2017). Did creatinine standardization give benefits to the evaluation of glomerular filtration rate? eJIFCC: Electronic journal of the International Federation of Clinical Chemistry and Laboratory Medicine, 28 (4), 251-257.

SCHLECK, M.-L., Souberbielle, J.-C., DELANAYE, P., Plebani, M., & Cavalier, E. (2017). Parathormone stability in hemodialyzed patients and healthy subjects: comparison on non-centrifuged EDTA and serum samples with second- and third-generation assays. Clinical Chemistry and Laboratory Medicine, 55 (8), 1152-1159. doi:10.1515/cclm-2016-0914

Winckert, A., VRANKEN, L., BOEMER, F., Courtois, J., & Cavalier, E. (2017). L'hypophosphatasie. Revue Médicale de Liège, 72 (12), 547-551.

yayo, E., Yao-Papo, E., Gnionsahé, A., Monnet, D., Pottel, H., CAVALIER, E., & DELANAYE, P. (2017). DFG en population saine africaine : comparaison des performances de 11 équations d’estimation à marquer unique ou combinés, avec et sans facteur ethnique. Néphrologie et Thérapeutique, 13 (5), 277.

Dinic, M., Maillard, N., DELANAYE, P., KRZESINSKI, J.-M., SAINT-REMY, A., CAVALIER, E., & Mariat, C. (December 2016). Association entre taux circulants de matrix-gla protéine et rigidité artérielle en transplantation rénale [Paper presentation]. XVI réunion annuelle de la Société Francophone de Transplantation, Liège, Belgium.

Courtois, J., GADISSEUR, R., BERTHOLET, C., LUKAS, P., Cavalier, E., Gillard, N., & Quinting, B. (15 October 2016). Hunting for new wheat allergens : a 2D Immunoblot and mass spectrometry approach [Poster presentation]. 4th Food Allergy and Anaphylaxis meeting, Rome, Italy.

LADANG, A., VRANKEN, L., & CAVALIER, E. (October 2016). Unexpected high levels of Cobalamin (Vitamin B12): Numerous interferences are decreased by PEG treatment [Poster presentation]. Congrès de la société belge de médecine de laboratoire.

DELANAYE, P., & CAVALIER, E. (September 2016). Mesure du débit de filtration glomérulaire par la clearance plasmatique de l'iohexol: comparaison d'une procédure à prélèvements multiples et à un prélèvement unique [Poster presentation]. Premier congrès de la Société francophone de néphrologie dialyse et transplantation (SFNDT), Strasbourg, France.

LE GOFF, C., Kaux, J.-F., D'OTREPPE DE BOUVETTE, S., Goffaux, S., Fillet, M., Chapelle, J.-P., & Cavalier, E. (August 2016). Release of cardiac biomarkers during a cycling race. World Journal of Cardiovascular Diseases, 6 (8), 285-294.

Cavalier, E., Jandrain, B., Coffiner, M., Da Silva, S., De Niet, S., Vanderbist, F., & Souberbielle, J.-C. (May 2016). A Randomised, Cross-Over Study to Estimate the Influence of Food on the 25-Hydroxyvitamin D(3) Serum Level after Vitamin D(3) Supplementation. Nutrients, 8 (5). doi:10.3390/nu8050309

Ebert, N., DELANAYE, P., Shlipak, M., Jakob, O., Martus, P., Bartel, J., Gaedeke, J., van der Giet, M., Schuchardt, M., CAVALIER, E., & Schaeffner, E. (May 2016). Cystatin C standardization decreases assay variation and improves assessment of glomerular filtration rate. Clinica Chimica Acta, 456, 115-121. doi:10.1016/j.cca.2016.03.002

Le Goff, C., Kaux, J.-F., Cavalier, E., & Croisier, J.-L. (April 2016). Is isokinetic exercise dangerous for the heart? European Journal of Physical and Rehabilitation Medicine, 52 (suppl. 1 No. 2), 457.

CAVALIER, E., LUKAS, P., BEKAERT, A.-C., PEETERS, S., LE GOFF, C., Yayo, E., DELANAYE, P., & Souberbielle, J.-C. (2016). Analytical and clinical evaluation of the new Fujirebio Lumipulse G non-competitive assay for 25(OH)-vitamin D and three immunoassays for 25(OH)D in healthy subjects, osteoporotic patients, third trimester pregnant women, healthy African subjects, hemodialyzed and intensive care patients. Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2015-0923

DELANAYE, P., Flamant, M., CAVALIER, E., Guerber, F., Valloton, T., Moranne, O., Pottel, H., Boffa, J., & Mariat, C. (2016). Adaptation posologique des médicaments et fonction rénale : Quel(s) estimateur(s) faut-il choisir? Néphrologie et Thérapeutique, 12 (1), 18-31. doi:10.1016/j.nephro.2015.07.472

DELANAYE, P., LE GOFF, C., JOURET, F., & CAVALIER, E. (2016). Concordance between Iothalamate and Iohexol Plasma Clearance [letter to the editor]. American Journal of Kidney Diseases, 68 (2), 329-330. doi:10.1053/j.ajkd.2016.01.007

Ebert, N., DELANAYE, P., Shlipak, M., Jakob, O., Martus, P., Gaedek, J., Schurchardt, M., van der Giet, M., Bartel, J., CAVALIER, E., & Schaeffner, E. (2016). Cystatin C standardization decreases assay variation and improves assessment of GFR [Poster presentation]. LIII Congress of ERA-EDTA, Vienna, Austria.

JOURET, F., CAVALIER, E., & DELANAYE, P. (2016). Concordance between iothalamate and iohexol plasma clearances [Poster presentation]. LIII Congress of ERA-EDTA, Vienna, Austria.

Moreau, E., Bächer, S., Mery, S., Goff, C., Piga, N., Vogeser, M., Hausmann, M., & CAVALIER, E. (2016). Performance characteristics of the VIDAS 25-OH Vitamin D total assay - comparison with four immunoassays and two liquid chromatography-tandem mass spectrometry methods in a multicentric study. Clinical Chemistry and Laboratory Medicine. doi:10.1515/cclm-2014-1249

ROUSSEAU, A.-F., SOUBERBIELLE, J.-C., DELANAYE, P., Damas, P., & Cavalier, E. (2016). Fibroblast growth factor 23 in acute burn patients: Novel insights from an intact-form assay. Burns: Journal of the International Society for Burn Injuries. doi:10.1016/j.burns.2016.01.024

Sagou Yayo, E., Aye, E., Konan, J., Emième, A., Attoungbré, M., Gnionsahé, A., CAVALIER, E., Monnet, D., & DELANAYE, P. (2016). Inadéquation du facteur ethnique pour l’estimation du débit de filtration glomérulaire en population générale noire-africaine : résultats en Côte d’Ivoire. Néphrologie et Thérapeutique, 12 (6), 454-459. doi:10.1016/j.nephro.2016.03.006

Cavalier, E., Plebani, M., DELANAYE, P., & Souberbielle, J.-C. (November 2015). Considerations in parathyroid hormone testing. Clinical Chemistry and Laboratory Medicine, 53 (12), 1913-9. doi:10.1515/cclm-2015-0314

LE GOFF, C., Kaux, J.-F., Gergelé, L., Millet, G., Viallon, M., Croisille, P., & Cavalier, E. (September 2015). Impact of an ultra-trail of 330 km on plasma levels of cardiac biomarkers. European Journal of Sports Medicine, 3 (Suppl 1), 77.

Delvin, E., LE GOFF, C., CAVALIER, E., & Souberbielle, J.-C. (2015). Measurement of circulating 25-hydroxyvitamin D: A historical review. Practical Laboratory Medicine. doi:10.1016/j.plabm.2015.04.001

LE GOFF, C., Kaux, J.-F., Goffaux, S., & Cavalier, E. (May 2015). Cardiac Biomarkers and Cycling Race. Journal of Sports Science and Medicine, 14 (2 (eCollection 2015 Jun)), 475-476.

Castiglione, V., JOURET, F., Bruyère, O., DUBOIS, B., THOMAS, A., WALTREGNY, D., BEKAERT, A.-C., CAVALIER, E., & GADISSEUR, R. (February 2015). Epidémiologie de la lithiase urinaire sur base d'une analyse morpho-constitutionnelle. Néphrologie et Thérapeutique, 11, 42-49. doi:10.1016/j.nephro.2014.08.003

Cavalier, E. (2015). APPROCHE GLOBALE ET PERSONNALISEE DES BIOMARQUEURS. Revue Médicale de Liège, 70 (5-6), 257-61.

DELANAYE, P., DUBOIS, B., LUKAS, P., PETERS, P., KRZESINSKI, J.-M., Pottel, H., & CAVALIER, E. (2015). impact of stopping vitamin K antagonist therapy on concentrations of dephospho-uncarboxylated Matrix Gla protein [letter to the editor]. Clinical Chemistry and Laboratory Medicine, 53 (8), 191-193. doi:10.1515/cclm-2015-0073

DELANAYE, P., LAMBERMONT, B., MORIMONT, P., KRZESINSKI, J.-M., Maillard, N., Claisse, G., Mariat, C., & CAVALIER, E. (2015). Discrepancies between urinary and plasma NGAL concentrations in patients adlmitted to the medical intensive care [Poster presentation]. LII Congress of ERA-EDTA, London, United Kingdom.

Deroyer, C., Magne, J., Moonen, M., Le Goff, C., Dupont, L., Hulin, A., Radermecker, M., Colige, A., Cavalier, E., Kolh, P., Pierard, L., LANCELLOTTI, P., Merville, M.-P., & Fillet, M. (2015). New biomarkers for primary mitral regurgitation. Clinical Proteomics, 12, 25. doi:10.1186/s12014-015-9097-2

Libon, F., SEIDEL, L., CAVALIER, E., & NIKKELS, A. (2015). Vitamin D supplementation does not improve the severity or the resolution of ultraviolet B-induced acute erythema. Dermatology, 231, 280-285. doi:10.1159/000430983

Raizman, J., Diamantis, E., Holmes, D., Stowasser, M., Auchus, R., & Cavalier, E. (2015). A Renin-ssance in primary aldosteronism testing: obstacles and opportunities for screening, diagnosis, and management. Clinical Chemistry, 61 (8), 1022-1027.

SCHLECK, M.-L., Souberbielle, J.-C., JANDRAIN, B., Da Silva, S., De Niet, S., Vanderbist, F., SCHEEN, A., & CAVALIER, E. (2015). A Randomized, Double-Blind, Parallel Study to Evaluate the Dose-Response of Three Different Vitamin D Treatment Schemes on the 25-Hydroxyvitamin D Serum Concentration in Patients with Vitamin D Deficiency. Nutrients, 7, 5413-22. doi:10.3390/nu7075227

ROUSSEAU, A.-F., & CAVALIER, E. (11 November 2014). Vitamin D status in critically ill patients: back to basics! [letter to the editor]. Critical Care, 18 (6), 611. doi:10.1186/s13054-014-0611-0

Castiglione, V., JOURET, F., Bruyère, O., BEKAERT, A.-C., THOMAS, A., DUBOIS, B., WALTREGNY, D., CAVALIER, E., & GADISSEUR, R. (17 October 2014). Épidémiologie de la lithiase urinaire en Province de Liège [Paper presentation]. Confrontations clinico-biologiques autour de la lithiase urinaire, Paris, France.

Castiglione, V., Jouret, F., Bruyère, O., BEKAERT, A.-C., DUBOIS, B., THOMAS, A., WALTREGNY, D., CAVALIER, E., & GADISSEUR, R. (01 October 2014). Épidémiologie de la lithiase urinaire en Province de Liège. Néphrologie et Thérapeutique, 10 (5), 270.

CAVALIER, E., BEKAERT, A.-C., LUKAS, P., PEETERS, S., GADISSEUR, R., LE GOFF, C., & DELANAYE, P. (October 2014). Les résultats des formules de calcul de la 25(OH)-vitamine D libre varient en fonction des méthodes de dosage de la 25(OH)D [Poster presentation]. 16ème Réunion commune - Société de néphrologie - Société de dialyse, Saint-Etienne, France.

CAVALIER, E., DUBOIS, B., BEKAERT, A.-C., LUKAS, P., PEETERS, S., GADISSEUR, R., LE GOFF, C., KRZESINSKI, J.-M., & DELANAYE, P. (October 2014). La membrane de dialyse peut-elle avoir une influence sur le statut en vitamine D du patient? [Poster presentation]. 16ème réunion commune - Société de néphrologie - Société de dialyse, Saint Etienne, France.

CAVALIER, E., PONCIN, J., MUSSO, G., & HALENG, J. (October 2014). Evaluation de la mesure rapide de la creatinine par le StaSensor (Nova Biomedical) [Poster presentation]. 16ème réunion commune - Société de néphrologie - Société de dialyse, Saint Etienne, France.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Moonen, M., Smelten, N., Médart, Pottel, H., & CAVALIER, E. (September 2014). Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrology, 15, 145. doi:10.1186/1471-2369-15-145

CAVALIER, E., DELANAYE, P., LUKAS, P., CARLISI, I., GADISSEUR, R., & Souberbielle, J.-C. (01 August 2014). Standardization of DiaSorin and Roche automated third generation PTH assays with an international standard: impact on clinical populations. Clinical Chemistry and Laboratory Medicine, 52 (8), 1137-41. doi:10.1515/cclm-2013-1027

CAVALIER, E., Mismetti, V., & Souberbielle, J.-C. (July 2014). Evaluation of circulating irisin levels in healthy young individuals after a single 100,000 IU vitamin D dose. Annales d'Endocrinologie, 73 (3), 162-164. doi:10.1016/j.ando.2014.05.005

LE GOFF, C., DELCOUR, S., PEETERS, S., CRINE, Y., NETCHACOVITCH, M., & Cavalier, E. (June 2014). URINARY AND SALIVARY CORTISOL IN LIQUID CHROMATOGRAPHY–TANDEM MASS SPECTROMETRY: METHOD VALIDATION AND EXPECTED VALUES DETERMINATION. Clinical Chemistry and Laboratory Medicine, 52 (Special Suppl), 1241.

LE GOFF, C., EVRARD, S., BREVERS, E., Kaux, J.-F., & Cavalier, E. (June 2014). Evaluation of troponin T on AQT90 Flex and COBAS 8000 as a rule in/out tool in an emergency ward. Clinical Chemistry and Laboratory Medicine, 52 (Special Suppl), 510.

LE GOFF, C., Kaux, J.-F., LAURENT, T., Vannuscorps, J., PINCEMAIL, J., Chapelle, J.-P., Cavalier, E., & Croisier, J.-L. (May 2014). Is isokinetic eccentric exercise dangerous for the heart? Isokinetics and Exercise Science, 22 (2), 131-136. doi:10.3233/IES-130529

CAVALIER, E., LUKAS, P., CRINE, Y., PEETERS, S., CARLISI, I., LE GOFF, C., GADISSEUR, R., DELANAYE, P., & Souberbielle, J.-C. (April 2014). Standardization of 25-hydroxyvitamin D assays: impact of vitamin-D binding protein concentrations and uremic media on the re-standardization of six different 25(OH) vitamin D immunoassays [Poster presentation]. WCO-IOF-ESCEO Seville 2014 : World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal diseases, Séville, Spain.

LE GOFF, C., Kaux, J.-F., Fillet, M., MELON, P., & Cavalier, E. (April 2014). Two biomarkers for the screening of cardiac risk among runners ? British Journal of Sports Medicine, 48 (7), 174.

LE GOFF, C., Kaux, J.-F., Fillet, M., MELON, P., & Cavalier, E. (April 2014). Cardiac troponins and natriuretic peptides in runners: useful for cardiac risk screening ? British Journal of Sports Medicine, 48 (7), 173. doi:10.1136/bjsports-2014-093494.173

ROUSSEAU, A.-F., BARGUES, L., LE BEVER, H., VEST, P., CAVALIER, E., LEDOUX, D., PIERARD, G., & DAMAS, P. (April 2014). Effect of gamma-hydroxybutyrate on keratinocytes proliferation: a preliminary prospective controlled study in severe burn patients. International Journal of Critical Illness and Injury Science, 4 (2), 108-113. doi:10.4103/2229-5151.134150

LUTTERI, L., PESSER, M., WATRIN, P., & CAVALIER, E. (March 2014). ANTI-NUCLEAR ANTIBODIES : PREVALENCE OF DIFFERENT PATTERNS AND ANTIBODIES IN A BELGIAN UNIVERSITY LABORATORY [Poster presentation]. 9ème congrès international d’auto-immunité, Nice, France.

LUTTERI, L., PESSER, M., WATRIN, P., & CAVALIER, E. (March 2014). A PAPERLESS AUTOIMMUNITY LABORATORY : IS IT POSSIBLE ? [Poster presentation]. 9ème congrès international d’auto-immunité.

DELANAYE, P., CAVALIER, E., Morel, J., Mehdi, M., Maillard, N., Claisse, G., LAMBERMONT, B., DUBOIS, B., DAMAS, P., KRZESINSKI, J.-M., Lautrette, A., & Mariat, C. (13 January 2014). Detection of decreased glomerular filtration rate in intensive care units: serum cystatin C versus serum creatinine. BMC Nephrology, 15 (9), 1471-2369. doi:10.1186/1471-2369-15-9

BOUQUEGNEAU, A., Vidal-Petiot, E., Vrtovsnik, F., CAVALIER, E., KRZESINSKI, J.-M., Flamant, M., & DELANAYE, P. (2014). Accuracy of Cockcroft&Gault and CKD-EPI equations to estimate glomerular filtration rate in obese population [Poster presentation]. LI Congress of ERA-EDTA, Amsterdam, Netherlands.

BOUQUEGNEAU, A., Vidal-Petito, E., Vrtovsnik, F., CAVALIER, E., KRZESINSKI, J.-M., Flamant, M., & DELANAYE, P. (2014). Cockcroft&Gault and CKD-EPI equations: are these equations concordant to adjust drug dosage? [Poster presentation]. LI Congress of ERA-EDTA, Amsterdam, Netherlands.

DELANAYE, P., DUBOIS, B., LUKAS, P., PETERS, P., KRZESINSKI, J.-M., & CAVALIER, E. (2014). Impact of the stopping of vitamin K antagonist treatment on concentrations of Dephosphorylated and uncarboxylated Matrix Gla protein [Poster presentation]. ASN Kidney Week, Philadelphia, United States - Pennsylvania.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Moonen, M., Smelten, N., Médart, L., Pottel, H., & CAVALIER, E. (2014). Sclerostin concentration is not predictive of mortality in hemodialysis patients [Poster presentation]. LI Congress of ERA-EDTA, Amsterdam, Netherlands.

DELANAYE, P., LAMBERMONT, B., MORIMONT, P., KRZESINSKI, J.-M., Maillard, N., Claisse, M., Mariat, C., & CAVALIER, E. (2014). Mesure du NGAL dans le sang et les urines : comparaison des méthodes de mesure et éventuel impact sur la décision clinique [Poster presentation]. XVI réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Saint-Etienne, France.

DELANAYE, P., Souberbielle, J.-C., GADISSEUR, R., DUBOIS, B., Krzesinski, J.-M., & CAVALIER, E. (2014). Inter-method variability in bone alkaline phosphatase measurement: clinical impact on the management of dialysis patients [Poster presentation]. LI Congress of ERA-EDTA, Amsterdam, Netherlands.

DELANAYE, P., WEEKERS, L., Warling, X., Moonen, M., Smelten, N., KRZESINSKI, J.-M., & CAVALIER, E. (2014). Effet de la vitamine D native sur la concentration de parathormone chez le patient hémodialysé : y a-t-il un intérêt au dosage de la parathormone non oxydée ? [Poster presentation]. XVI réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Saint-Etienne, France.

Kuster, N., Cristol, J.-P., CAVALIER, E., Bargnoux, A.-S., Halimi, J.-M., Froissart, M., Piéroni, L., & DELANAYE, P. (January 2014). Enzymatic creatinine assays allowestimation of glomerular filtration rate in stages 1 and 2 chronic kidney disease using CKD-EPI equation. Clinica Chimica Acta, 428, 89-95. doi:10.1016/j.cca.2013.11.002

ROUSSEAU, A.-F., FOIDART-DESSALLE, M., REMY, C., LEDOUX, D., DAMAS, P., & CAVALIER, E. (2014). Effect of optimized cholecalciferol and calcium intakes on bone mineral density: a randomized controlled trial in adult burns during sequelae stage. Nutrients, 6, 2771.

Sepulchre, E., LUTTERI, L., CAVALIER, E., Guerci, B., & RADERMECKER, R. (2014). A propos de l'hémoglobine glyquée: Les limites de son interprétation. Revue Médicale de Liège, 69 (9), 497-503.

Beaudart, C., Buckinx, F., Rabenda, V., GILLAIN, S., CAVALIER, E., Slomian, J., PETERMANS, J., Reginster, J.-Y., & Bruyère, O. (28 November 2013). Les effets d’une supplémentation en vitamine D sur la force musculaire : une méta-analyse d’essais randomisés contrôlés [Paper presentation]. Journée des Doctorants de l'Ecole Doctorale "SPSS", Bruxelles, Belgium.

CAVALIER, E., & DELANAYE, P. (08 November 2013). PINP in renal impaired patients: the assay matters [Poster presentation]. ASN Kidney week, Atlanta, United States.

CAVALIER, E., & DELANAYE, P. (08 November 2013). Performance of a novel fully automated method for the detection of dephospho-uncarboxylated matrix gla ptrotein (dp-ucMGP) [Poster presentation]. ASN Kidney week, Atlanta, United States.

CAVALIER, E., & DELANAYE, P. (08 November 2013). Inter-method variability for the measurement of bone alkaline phosphatase: Implication for the monitoring of CKD-MBD [Poster presentation]. ASN Kidney week, Atlanta, United States.

CAVALIER, E., & DELANAYE, P. (08 November 2013). Analytical performance of a new bone specific ALP automated immunoassay [Poster presentation]. ASN Kidney week, Atlanta, United States.

Brunel, E., SCHNITZLER, M., Foidart-Dessalle, M., Souberbielle, J.-C., & CAVALIER, E. (2013). A Double-Blind, Placebo Controlled, Randomized Trial to Assess the Impact of a Monthly Administration of 50,000 IU of Vitamin D3 for 6 Months on Serum Levels of 25-Hydroxyvitamin D in Healthy Young Adults. International Journal of Endocrinology. doi:10.1155/2013/652648

VALDES SOCIN, H. G., SYRIOS, P., GADISSEUR, R., TEIXEIRA, J., LUYCKX, F., BECKERS, A., & CAVALIER, E. (November 2013). Persistent low levels of serum hCG: please do not miss phantom hCG! (pseudohypergonadotropinemia syndrome). Acta Clinica Belgica, 68 (6), 465.

CAVALIER, E., LUKAS, P., CARLISI, I., GADISSEUR, R., & DELANAYE, P. (October 2013). Aminoterminal propeptide of type I procollagen (P1NP) in chronic kidney disease patients: the assay matters [letter to the editor]. Clinica Chimica Acta, 425, 117-118.

CAVALIER, E., ROUSSELLE, O., FERRANTE, N., CARLISI, I., LE GOFF, C., & Souberbielle, J.-C. (October 2013). Technical and clinical evaluation of the VITROS Immunodiagnostic Products 25-OH Vitamin D Total Assay - comparison with marketed automated immunoassays and a liquid chromatography - tandem mass spectrometry method. Clinical Chemistry and Laboratory Medicine, 51 (10), 1983-1989. doi:10.1515/cclm-2013-0138

DELANAYE, P., & CAVALIER, E. (October 2013). Staging chronic kidney disease and estimating glomerular filtration rate: an opinion paper about the new international recommendations. Clinical Chemistry and Laboratory Medicine, 51 (10), 1911-1917. doi:10.1515/cclm-2013-0223

Morovat, A., Catchpole, A., MEURISSE, A., CARLISI, I., BEKAERT, A.-C., ROUSSELLE, O., paddon, M., James, T., & CAVALIER, E. (October 2013). IDS iSYS automated intact procollagen-1-Nterminus pro-peptide assay: method evaluation and reference intervals in adults and children. Clinical Chemistry and Laboratory Medicine, 51 (10), 2009-2018. doi:10.1515/cclm-2012-0531

LE GOFF, C., Kaux, J.-F., Leroy, L., PINCEMAIL, J., Chapelle, J.-P., & Cavalier, E. (September 2013). Fatty acids and associated cardiovascular risk. Food and Nutrition Sciences, 4 (9A), 188-194.

LE GOFF, C., Kaux, J.-F., MELON, P., Fillet, M., CHAPELLE, J.-P., & Cavalier, E. (September 2013). Running races: study of the stress and cardiac biomarkers. European Journal of Sports Medicine, 1 (Supplement 1), 212.

CAVALIER, E., LUKAS, P., CARLISI, I., & Souberbielle, J.-C. (July 2013). Standardization of 25-hydroxyvitamin D assays: impact of vitamin-D binding protein concentrations and uremic media on the restandarization of six different 25 (OH) vitamin D immunoassays [Poster presentation]. AACC Annual meeting 2013, Houston, United States.

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Smelten, N., & CAVALIER, E. (July 2013). VITAMIN K ANTAGONISTS IN HEMODIALYSIS PATIENTS: IMPACT ON THE PLASMA LEVELS OF DEPHOSPHO-UNCARBOXYLATED MATRIX GLA-PROTEIN [Poster presentation]. AACC Annual meeting 2013, Houston, United States.

GADISSEUR, R., LUKAS, P., CARLISI, I., & CAVALIER, E. (July 2013). Performance of the IDS-iSYS 1,25-dihydroxy vitamin D assay [Poster presentation]. AACC Annual meeting, Houston, United States.

GADISSEUR, R., LUKAS, P., CARLISI, I., & CAVALIER, E. (July 2013). Analytical performance of the IDS-iSYS N-Mid osteocalcin immunoassay [Poster presentation]. AACC Annual meeting 2013, Houston, United States.

LE GOFF, C., MELON, P., BREVERS, E., Fillet, M., Kaux, J.-F., Chapelle, J.-P., & Cavalier, E. (2013). Comparison of the Heart-type fatty acid-binding protein (H-FABP) with the high sensitive cardiac troponin T in healthy runners. In Book of abstracts of 18th Annual Congress of the ECSS (pp. 465).

LE GOFF, C., Kaux, J.-F., BREVERS, E., Fillet, M., MELON, P., CHAPELLE, J.-P., & Cavalier, E. (May 2013). Comparison of the Heart-type fatty acid-binding protein (H-FABP) with the high sensitive cardiac troponin T in healthy runners. Biochimica Clinica, 37 (SS), 544.

LE GOFF, C., Kaux, J.-F., MELON, P., Fillet, M., CHAPELLE, J.-P., & Cavalier, E. (May 2013). Race Cycling: biological evolution. Biochimica Clinica, 37 (SS), 544.

LE GOFF, C., MELON, P., Kaux, J.-F., Fillet, M., CHAPELLE, J.-P., & Cavalier, E. (May 2013). Impact of strenuous exercise on the release of cardiac biomarkers. Biochimica Clinica, 37 (SS), 545.

LE GOFF, C., PEETERS, S., CRINE, Y., NETCHACOVITCH, M., Kaux, J.-F., & Cavalier, E. (May 2013). Comparison between Perkin-Elmer and Chromsytem Vitamin D kit on TQ 5500 from AB SCIEX. Biochimica Clinica, 37 (SS), 471.

LE GOFF, C., PEETERS, S., NETCHACOVITCH, M., Kaux, J.-F., CRINE, Y., & Cavalier, E. (May 2013). Determination of urinary metanephrine, normetanephrine and methoxymetanephrine by liquid chromatography-electrospray tandem mass spectrometry. Biochimica Clinica, 37 (SS), 316.

BOUQUEGNEAU, A., CAVALIER, E., Krzesinski, J.-M., & DELANAYE, P. (18 April 2013). MDRD VERSUS CKD-EPI EQUATIONS TO ESTIMATE GLOMERULAR FILTRATION RATE IN OBESE PATIENTS [Poster presentation]. 50th ERA-EDTA Congress, Istanbul, Turkey.

DELANAYE, P., CAVALIER, E., Moranne, O., LUTTERI, L., KRZESINSKI, J.-M., & Bruyère, O. (12 March 2013). Creatinine - or cystatin C - based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease. BMC Nephrology, 14, 57. doi:10.1186/1471-2369-14-57

VRANKEN, L., CAVALIER, E. (Other coll.), & VALDES SOCIN, H. G. (Other coll.). (01 March 2013). Holotranscobalamin versus Total Vitamin B12 as Indicators of Vitamin B12 deficiency in Thyrogastric Syndrome [Poster presentation]. Belgian week of gastroenterology, Anvers, Belgium.

Bruyère, O., Slomian, J., Beaudart, C., Buckinx, F., CAVALIER, E., GILLAIN, S., Petermans, J., & REGINSTER, J.-Y. (2013). Prevalence of vitamin D inadequacy in European postmenopausal women aged over 80 years. European Geriatric Medicine, 4 (S1), 13-S14.

CAVALIER, E., Faché, W., & Souberbielle, J.-C. (2013). A randomised, double-blinded, placebo-controlled, parallel study of vitamin D3 supplementation with different schemes based on multiples of 25,000 IU doses. International Journal of Endocrinology. doi:10.1155/2013/327265

CAVALIER, E., Thervet, E., & Courbebaisse, M. (2013). Vitamine D et rein. Presse Médicale, 42, 1391-1397. doi:10.1016/j.lpm.2013.07.011

DELANAYE, P., KRZESINSKI, J.-M., Warling, X., Smelten, N., Pottel, H., & CAVALIER, E. (2013). Variables cliniques et biologiques associées à la mortalité du patient hémodialysé [Poster presentation]. XV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Nantes, France.

Masson, I., Flamant, M., Maillard, N., CAVALIER, E., Moranne, O., Alamartine, E., Mariat, C., & DELANAYE, P. (2013). MDRD versus CKD-EPI equation to estimate glomerular filtration rate in kidney transplant recipients [Poster presentation]. L Congress of ERA-EDTA, Istanbul, Turkey.

Pirotte, B., Rassenfosse, M., Collin, R., De Voeght, A., MOUTSCHEN, M., & CAVALIER, E. (2013). Rôle de la vitamine D dans l'infection par le VIH: revue des connaissances actuelles. Revue Médicale de Liège, 68 (1), 25-31.

Souberbielle, J.-C., & CAVALIER, E. (2013). Supplementation, optimal status, and analytical determination of vitamin D: Where are we standing in 2012? Anti-Cancer Agents in Medicinal Chemistry, 1, 36-44. doi:10.2174/187152013804487317

VALDES SOCIN, H. G., LUTTERI, L., CAVALIER, E., POLUS, M., LOUIS, E., & BECKERS, A. (2013). le syndrome auto-immun thyrogastrique: ses effets sur les micronutriments et la tumorigénèse gastrique. Revue Médicale de Liège.

Vidal-Petiot, E., DELANAYE, P., BOUQUEGNEAU, A., Vrtovsnik, F., CAVALIER, E., & Flamant, M. (2013). Estimation du débit de filtration glomérulaire chez l’obèse : MDRD ou CKD-EPI ? [Poster presentation]. XV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Nantes, France.

COLSON, L., Vander Rest, C., Reginster, J.-Y., DELANAYE, P., CAVALIER, E., LE GOFF, C., Crielaard, J.-M., & Kaux, J.-F. (December 2012). Ostéomalacie hypophosphatémique hyperphosphaturique avec hypersécrétion de FGF-23. Lettre du Rhumatologue, 387, 26-29.

Gagneux-Brunon, A., DELANAYE, P., LEGRAND, D., CAVALIER, E., & Mariat, C. (December 2012). NGAL biomarqueur de lésion rénale. Néphrologie et Thérapeutique, 8 (7), 508-515. doi:10.1016/j.nephro.2012.03.006

LE GOFF, C., Kaux, J.-F., Leroy, L., Cavalier, E., & Chapelle, J.-P. (October 2012). Le dosage des acides gras érythrocytaires : comparaison entre une population de référence et des sujets ayant présenté un infarctus aigu du myocarde. Immuno-Analyse and Biologie Spécialisée, 27 (5), 237-243. doi:10.1016/j.immbio.2012.04.003

CAVALIER, E. (18 July 2012). Analytical performance of two Thyroglobulin assays in the low range: impact on clinical decisions [Poster presentation]. AACC 2012, Los Angeles, United States.

HAMDI, E., DELANAYE, P., LUTTERI, L., CHAPELLE, J.-P., & CAVALIER, E. (18 July 2012). analytical and Clinical Validation of Beta-Trace Protein, a New Marker of Glomerular Filtration Rate [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E. (17 July 2012). Evaluation of the Liaison 25-OH Vitamin D Total assay on the new Liaison XL analyser [Paper presentation]. AACC - booth presentation, Los Angeles, United States.

CAVALIER, E., CARLISI, I., FERRANTE, N., BEKAERT, A.-C., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Performance of the IDS-iSYS CROSSLAPS (CTX-I) Automated Immunoassay [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Evaluation of the Liaison 25-OH Vitamin D TOTAL Assay on the new DiaSorin Liaison XL [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., FERRANTE, N., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (17 July 2012). Evaluation of Sclerostin levels in patients suffering from Chronic Kidney Diseases [Poster presentation]. AACC 2012, Los Angeles, United States.

CAVALIER, E., CARLISI, I., MEURISSE, A., FERRANTE, N., ROUSSELLE, O., & CHAPELLE, J.-P. (17 July 2012). Analytical Verification of the IDS-iSYS Intact Amino-terminal Propeptide of Type 1 Procollagen (P1NP) [Poster presentation]. AACC 2012, Los Angeles, United States.

LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., CHAPELLE, J.-P., & CAVALIER, E. (17 July 2012). Evaluation of the Cross-reactivity of 25-Hydroxy-vitamin D2 on Six Commercial Immunoassays on Native Samples [Poster presentation]. AACC 2012, Los Angeles, United States.

LE GOFF, C., PEETERS, S., CRINE, Y., LUKAS, P., CHAPELLE, J.-P., & CAVALIER, E. (17 July 2012). Analytical validation of the Perkin-Elmer MSMS Vit D for 25-Hydroxy-vitamin D determination on AB SCIEX TQ5500 [Poster presentation]. AACC 2012, Los Angeles, United States.

Greiner, C, Remy, B., CAVALIER, E., Gabriel, A., & Carstanjen, B. (2012). Bone markers in pregnant Haflinger mares _ A trimestral evaluation. In Procedings of the Hippos-Congress 2012.

LE GOFF, C., Leroy, L., Kaux, J.-F., CAVALIER, E., & Chapelle, J.-P. (February 2012). Le dosage des acides gras érythrocytaires : comparaison entre une population de référence et des sujets ayant présenté un infarctus aigu du myocarde [Poster presentation]. 28e Colloque IBS CORATA, Namur, Belgium.

GADISSEUR, R., & CAVALIER, E. (2012). Lait et métabolisme phosphocalcique. In CIAB ALLER-J Club d'Immuno-Allergologie Biologique.

DELANAYE, P., CARLISI, I., ROUSSELLE, O., FERRANTE, N., KRZESINSKI, J.-M., & CAVALIER, E. (2012). Utilisation du propeptide N-terminal du procollagène de type 1 (P1NP) comme marqueur de formation osseuse chez le patient insuffisant rénal : différence entre le dosage total et le dosage « intact » [Poster presentation]. XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland.

DELANAYE, P., CAVALIER, E., DUBOIS, B., & KRZESINSKI, J.-M. (2012). Adhésion thérapeutique du patient hémodialysé [Poster presentation]. XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland.

DELANAYE, P., CAVALIER, E., Masson, I., Mehdi, Maillard, N., LAMBERMONT, B., DAMAS, P., KRZESINSKI, J.-M., Morel, J., Lautrette, A., & Mariat, C. (2012). Detection of decreased glomerular filtration rate in intensive care units: interest of cystatin C [Poster presentation]. XLIX congress of ERA-EDTA, Paris, France.

DELANAYE, P., DUBOIS, B., KRZESINSKI, J.-M., & CAVALIER, E. (2012). Compliance of the hemodialysis patient to the native vitamin D therapy [Poster presentation]. XLIX Congress of ERA-EDTA, Paris, France.

DELANAYE, P., WEEKERS, L., Warling, X., Moonen, M., Smelten, N., Médart, L., KRZESINSKI, J.-M., & CAVALIER, E. (2012). Vitamine D native chez le patient hémodialysé: efficacité et profil de sécurité. Une étude multicentrique, prospective et randomisée contre placebo sur un an [Poster presentation]. XIV réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Genève, Switzerland.

FAILLA, V., CAVALIER, E., EL HAYDERI, L., PAUROBALLY, D., Chapelle, J.-P., DEZFOULIAN, B., & NIKKELS, A. (2012). Seasonal variations in vitamin D levels in melanoma patients: a single-centre prospective pilot comparative study. Journal of the European Academy of Dermatology and Venereology, 26 (5), 651-3. doi:10.1111/j.1468-3083.2011.04087.x

CAVALIER, E. (2011). Séminaire de Chimie médicale - Les Immunoassays. (ULiège - Université de Liège, Bioc0341-1 - Biochimie pathologique y compris Chimie médicale: partim 1).

Pilz, S., Tomaschitz, A., März, W., Drechsler, C., Ritz, E., Zittermann, A., CAVALIER, E., Pieber, T., Lappe, J., Grant, W., Holick, M., & Dekker, J. (November 2011). Vitamin D, cardiovascular disease and mortality. Clinical Endocrinology, 75 (5), 575-84. doi:10.1111/j.1365-2265.2011.04147.x

DE BACKER, B., Poncin, J., HALENG, J., CHAPELLE, J.-P., & CAVALIER, E. (15 October 2011). Comparison between the new AccuChek Inform II glucose meter and the Rapidlab 865 blood gas analyzer: implications for use of the Inform II in tight glycemic control [Poster presentation]. BVKB - SBBC (Belgian Society for Clinical Biology) Annual Symposium 2011, Liège, Belgium.

CAVALIER, E., DELANAYE, P., & Souberbielle, J.-C. (October 2011). Maintenir la PTH entre 2 et 9 fois la valeur de référence supérieure du Laboratoire: d'accord, mais quelle valeur? Néphrologie et Thérapeutique, 7 (5), 411-447 (Pub 27.

CAVALIER, E., & Souberbielle, J.-C. (18 September 2011). Establishment of Parathyroid hormone reference range on 10 different assay kits: impact of the recruitment of the population [Poster presentation]. ASBMR 2011 Annual Meeting, San-Diego, United States.

CAVALIER, E., BEKAERT, A.-C., CARLISI, I., & CHAPELLE, J.-P. (17 September 2011). Automated Measurement of Total 25OH Vitamin D in the IDS iSYS System [Poster presentation]. ASBMR 2011 Annual Meeting, San-Diego, United States.

CAVALIER, E., & DELANAYE, P. (September 2011). Nouveautés sur la stabilité de la parathormone telle que mesurée à l'aide d'un kit de troisième génération: impact sur la pratique quotidienne. Néphrologie et Thérapeutique, 7 (5), 284-85.

CAVALIER, E., DELANAYE, P., Souberbielle, J.-C., & RADERMECKER, R. (September 2011). Vitamin D and type 2 diabetes mellitus: Where do we stand? Diabetes and Metabolism, 37 (4), 265-72. doi:10.1016/j.diabet.2011.01.001

DELANAYE, P., CAVALIER, E., & KRZESINSKI, J.-M. (September 2011). Détection de la maladie rénale chronique dans la population générale: créatinine ou cystatine C? [Poster presentation]. 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

DELANAYE, P., CAVALIER, E., & KRZESINSKI, J.-M. (September 2011). Définition d'un débit de filtration "normal" fixe ou adapté à l'âge et au genre: impact sur l'épidémiologie de la maladie rénale chronique [Poster presentation]. 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

DELANAYE, P., CAVALIER, E., Mariat, C., Maillard, N., KRZESINSKI, J.-M., & White, C. (September 2011). Trimethoprim, creatinine and creatinine-based equations. Kidney International, 80 (5), 439-40. doi:10.1159/000328911

DELANAYE, P., KRZESINSKI, J.-M., & CAVALIER, E. (September 2011). Suivi longitudinal des concentrations de PTH et de phosphatase alcaline osseuse chez le sujet hémodialysé: mesure-t-on la même chose? [Poster presentation]. 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

DELANAYE, P., KRZESINSKI, J.-M., & CAVALIER, E. (September 2011). Suivi à court et à long terme de la concentration de parathormone chez le patient hémodialysé: dosage de seconde et troisième génération [Poster presentation]. 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

Masson, I., Maillard, N., Jaafar, A., Thibaudin, L., Dubourg, L., DELANAYE, P., CAVALIER, E., Bonneau, F., Kamar, N., Morelon, E., Alarmatine, E., & Mariat, C. (September 2011). Estimation du débit de filtration glomérulaire en transplantation rénale: étude multicentrique d'évaluation de la performance de la cystatine C [Poster presentation]. 13e Réunion commune de la Société Francophone de Dialyse (SFD) et de la Société de Néphrologie (SN), Bordeaux, France.

VAN DER REST, C., CAVALIER, E., COLSON, L., KAUX, J.-F., KRZESINSKI, J.-M., REGINSTER, J.-Y., HUSTINX, R., & DELANAYE, P. (August 2011). Hypophosphatémie et ostéomalacie oncogénique. Revue Médicale Suisse, 7, 1630-3.

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., GUADAGNI, A., ROUSSELLE, O., CHAPELLE, J.-P., & DELANAYE, P. (28 July 2011). New insights on the stability of the (1-84) PTH as determined with an automated 3rd generation PTH assay [Poster presentation]. AACC, Atlanta, United States.

CAVALIER, E., DELANAYE, P., Vranken, L., CARLISI, I., BEKAERT, A.-C., CHAPELLE, J.-P., & Souberbielle, J.-C. (28 July 2011). Impact of the use of the Manufacturer's published reference range for PTH vs. the reference range established in the Laboratory for the classification of the haemodialyzed patients with the KDIGO Guidelines [Poster presentation]. AACC, Atlanta, United States.

CAVALIER, E., PONCIN, J., MUSSO, G., HALENG, J., & CHAPELLE, J.-P. (27 July 2011). Analytical validation of Accu-check Inform II meters and strips before their use in the wards: practical experience of the CHU de Liège [Poster presentation]. AACC 2011, Atlanta, United States.

WEEKERS, L., Warling, X., Moonen, M., Smelten, N., Medart, L., Krzesinski, J.-M., CAVALIER, E., & DELANAYE, P. (25 June 2011). Native vitamin D in dialysis patients : safety and biological effects [Paper presentation]. XLVIII ERA-EDTA, Prague, Czechia.

CAVALIER, E. (09 June 2011). Sommes-nous tous déficitaires en vitamine D? Correspondances en MHDN, 15 (6), 191-195.

CAVALIER, E. (June 2011). Are we all vitamin-D deficient? Correspondances en MHDN, 15 (6), 191-195.

CAVALIER, E. (18 May 2011). Practical Experience with a Validation and QC Management Program for PoC Testing [Paper presentation]. Roche Hospital Point-of-Care Symposium, Berlin, Germany.

CAVALIER, E. (May 2011). Vitamine D et aspects pratiques: quels dosages? pour qui? quelle supplémentation? [Paper presentation]. 2ème congrès du Groupe d'Etude de la Ménopause et du Vieillissement Hormonal (GEMVI), Paris, France.

CAVALIER, E. (May 2011). Vitamin D: clinical relevance, analytical issues. Clinical Chemistry and Laboratory Medicine, 49 (s1), 66.

CAVALIER, E., CARLISI, I., & DELANAYE, P. (May 2011). Human anti-animal antibodies: even today, it is still a problem in routine practice: illustration with 4 clinical cases. Clinical Chemistry and Laboratory Medicine, 49 (s1), 409.

LE GOFF, C., Leroy, L., Kaux, J.-F., CAVALIER, E., & Chapelle, J.-P. (May 2011). Fatty acids and cardiovascular risk. Clinical Chemistry and Laboratory Medicine, 49 (Special Suppl), 313.

Cavalier, E., Huberty, V., Carlisi, I., Chapelle, J.-P., Vroonen, L., & Beckers, A. (18 March 2011). Human anti-animal antibodies interference in the Siemens Immulite chemiluminescent insulin immuno-assay: about one case. Clinica Chimica Acta, 412 (7-8), 668-669. doi:10.1016/j.cca.2010.12.035

DELANAYE, P., MARIAT, C., KRZESINSKI, J.-M., & CAVALIER, E. (19 February 2011). Paricalcitol for reduction of albuminuria in diabetes [letter to the editor]. The Journal-Lancet, 377, 635. doi:10.1016/S0140-6736(11)60223-7

Bargnoux, A. S., Cavalier, E., Cristol, J. P., Simon, N., Dupuy, A. M., Garrigue, V., Delanaye, P., & Mourad, G. (February 2011). Cystatin C is a reliable marker for estimation of glomerular filtration rate in renal transplantation: validation of a new turbidimetric assay using monospecific sheep antibodies. Clinical Chemistry and Laboratory Medicine, 49 (2), 265-70. doi:10.1515/CCLM.2011.043

CAVALIER, E. (2011). Vitamine D et grossesse. (HELMO).

Cavalier, E., Huberty, V., Cormier, C., & Souberbielle, J.-C. (February 2011). Overestimation of the 25OHD serum concentration with the automated IDS EIA kit. Journal of Bone and Mineral Research, 26 (2), 434-6. doi:10.1002/jbmr.190

Bargnoux, A.-S., Boutten, A., Cambillau, M., Carlier, M.-C., CAVALIER, E., Cristol, J.-P., Hanser, A.-M., Piéroni, L., DELANAYE, P., Frimat, L., & Froissart, M. (January 2011). Recommandations pour le choix et l'harmonisation des techniques de dosage de la créatinine. Annales de Biologie Clinique, 69 (1), 9-16.

CAVALIER, E. (2011). 2ème BBM - ostéoporose.

Cavalier, E., Bekaert, A.-C., Carlisi, I., Legrand, D., Krzesinski, J.-M., & Delanaye, P. (2011). Neutrophil gelatinase-associated lipocalin (NGAL) determined in urine with the Abbott Architect or in plasma with the Biosite Triage? The laboratory's point of view. Clinical Chemistry and Laboratory Medicine, 49 (2), 339-341. doi:10.1515/CCLM.2011.044

CAVALIER, E., CARLISI, I., BEKAERT, A.-C., CHAPELLE, J.-P., & SOUBERBIELLE, J.-C. (2011). Validation of the Abbott Architect 25(OH)-vitamin D assay. Clinical Chemistry and Laboratory Medicine, 49 (s1), 418.

Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Chapelle, J.-P., & Delanaye, P. (2011). Analytical validation of the Liaison Calcitonin_II-Gen (DiaSorin). Clinical Chemistry and Laboratory Medicine, 49 (2), 271-275. doi:10.1515/CCLM.2011.036

DELANAYE, P., Souvignet, M., Dubourg, L., Thibaudin, L., Maillard, N., KRZESINSKI, J.-M., CAVALIER, E., & Mariat, C. (2011). Le dosage de l'inuline: mise au point. Annales de Biologie Clinique, 69 (3), 273-84. doi:10.1684/abc.2011.0580

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (2011). A new tool in the field of in-vitro diagnosis of allergy: preliminary results in the comparison of ImmunoCAP (c) 250 with the ImmunoCAP (c) ISAC. Clinical Chemistry and Laboratory Medicine, 49 (2), 277-80. doi:10.1515/CCLM.2011.052

Pieroni, L., DELANAYE, P., Boutten, A., Bargnoux, A.-S., Rozet, E., Delatour, V., Carlier, M.-C., Hanser, A.-M., CAVALIER, E., Froissart, M., & Cristol, J.-P. (2011). A multicentric evaluation of IDMS-traceable creatinine enzymatic assays. Clinica Chimica Acta, 412, 2070-2075. doi:10.1016/j.cca.2011.07.012

VALDES SOCIN, H. G., Cavalier, E., beckaert, A. C., Carlisi, A., Chavez, M., & Beckers, A. (2011). Elévation des kisspeptines plasmatiques chez les hommes obèses avec hypogonadisme acquis et chez les hommes avec hypogonadisme congénital : Etude pilote des modifications plasmatiques des kisspeptines avant et après administration de hCG et testostérone. In Annales d'Endocrinologie - 28ème congrès de la société Française d'Endocrinologie.

VROONEN, L., Cavalier, E., Vranken, L., VALDES SOCIN, H. G., PETROSSIANS, P., & Beckers, A. (2011). Influence of drospirenone on renin-angiotensin-aldosterone system evaluation. In Endocrine Abstracts - 13th European Congress of Endocrinology.

VROONEN, L., Cavalier, E., Vranken, L., VALDES SOCIN, H. G., PETROSSIANS, P., & Beckers, A. (2011). Drospirenone and interference with renin-antiotensin system. In Annales d'Endocrinologie - 28ème congrès de la société Française d'Endocrinologie.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (18 November 2010). Analyse morphoconstitutionnelle des lithiases [Paper presentation]. GLEM de Biologie Clinique, Fléron, Belgium.

Cavalier, E. (04 November 2010). Which career perspectives for young scientists? [Paper presentation]. Journées Internationales de Biologie, Paris, France.

Delanaye, P., & Cavalier, E. (2010). Vascular calcifications in dialysis patients.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (October 2010). New technologies in allergology, Workshop [Paper presentation]. Symposium BVKB/SBBC, Anvers, Belgium.

Pilz, S., Tomaschitz, A., März, W., Cavalier, E., & Ritz, E. (October 2010). Aldosterone and parathyroid hormone: a complex and clinically relevant relationship. Calcified Tissue International, 87 (4), 373-4. doi:10.1007/s00223-010-9409-5

Cavalier, E. (September 2010). Vitamin D and cardiovascular diseases: Where do we stand in 2010? Lipid Club Letter, 22 (3), 2-3.

Cavalier, E., Barguil, Y., Bourgeois, A. M., Boutten, A., Delanaye, P., Desch, G., Duvillard, L., Fellahi, S., Froissart, M., Piéroni, L., Rozet, E., & Cristol, J. P. (September 2010). Evaluation analytique de la cystatine C: résultats de l'étude multicentrique SN/SFBC. Néphrologie et Thérapeutique, 6 (5), 314.

Cavalier, E., Carlisi, I., Delanaye, P., Beckers, A., & Souberbielle, J.-C. (2010). Dosage de la 25-OH vitamine D: attention aux erreurs analytiques! Congrès de la Société Française d'Endocrinologie.

Cavalier, E., Delanaye, P., & Beckers, A. (2010). Les anticorps hétérophiles : une cause souvent méconnue d'erreurs de diagnostic. In 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010.

Cavalier, E., Delanaye, P., & Beckers, A. (2010). Détection précoce de l'hyperparathyroïdie secondaire : impact de l'établissement des valeurs de références de la parathormone. In 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010.

Cavalier, E., Jean, G., Delanaye, P., & Souberbielle, J.-C. (September 2010). Les cibles thérapeutiques pour la PTH dans les nouvelles recommandations du KDIGO: la fin d'un cauchemar? Néphrologie et Thérapeutique, 6 (5), 424.

Cavalier, E., Krzesinski, J.-M., & Delanaye, P. (September 2010). Mesure de la PTH chez le patient hémodialysé avec une trousse de 2è ou de 3è génération: impact pour le clinicien. Néphrologie et Thérapeutique, 6 (5), 397.

Cavalier, E., Rozet, E., Bekaert, A.-C., Legrand, D., Krzesinski, J.-M., & Delanaye, P. (September 2010). Le dosage urinaire et plasmatique du NGAL: étude analytique et implications pratiques pour le clinicien. Néphrologie et Thérapeutique, 6 (5), 350.

Delanaye, P., Cavalier, E., Mariat, C., Lambermont, B., Wiesen, P., Damas, P., & Krzesinski, J.-M. (September 2010). Intérêt de la cystatine C plasmatique pour la détection d'une insuffisance rénale chez le patient hospitalisé aux soins intensifs : résultats préliminaires [Poster presentation]. 12è Réunion commune de la Société de Néphrologie (SN) et de la Société Francophone de Dialyse (SFD), Bruxelles, Belgium.

Delanaye, P., Warling, X., Moonen, M., Smelten, N., Rozet, E., Médart, L., Weekers, L., Krzesinski, J.-M., & Cavalier, E. (September 2010). Quels paramètres cliniques et biologiques peuvent être considérés comme prédictifs des calcifications vasculaires chez le patient hémodialysé? [Poster presentation]. 12è Réunion commune de la Société de Néphrologie (SN) et de la Société Francophone de Dialyse (SFD), Bruxelles, Belgium.

Keutgens, A., Ho, T. T. G., & Cavalier, E. (2010). Analytical validation of the Liaison hGH assay (DiaSorin). In European NeuroEndocrine Association.

Souberbielle, J.-C., Body, J. J., Lappe, J. M., Plebani, M., Shoenfeld, Y., Wang, T. J., Bischoff-Ferrari, H. A., Cavalier, E., Ebeling, P. R., Fardellone, P., Gandini, S., Gruson, D., Guerin, A. P., Heickendorff, L., Hollis, B. W., Ish-Shalom, S., Jean, G., von Landenberg, P., Largura, A., ... Zittermann, A. (September 2010). Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmunity Reviews, 9 (11), 709-15. doi:10.1016/j.autrev.2010.06.009

Thibaudin, L., Delanaye, P., Maillard, N., Cavalier, E., Rozet, E., Alamartine, E., & Mariat, C. (September 2010). Comparaison d'une méthode "acide" et enzymatique pour le dosage de l'inuline [Poster presentation]. 12è Réunion commune de la Société de Néphrologie (SN) et de la Société Francophone de Dialyse (SFD), Bruxelles, Belgium.

Cavalier, E., Daly, A., Betea, D., Pruteanu-Apetrii, P. N., Delanaye, P., Stubbs, P., Bradwell, A. R., Chapelle, J.-P., & Beckers, A. (August 2010). The Ratio of Parathyroid Hormone as Measured by Third- and Second-Generation Assays as a Marker for Parathyroid Carcinoma. Journal of Clinical Endocrinology and Metabolism, 95, 3745-9. doi:10.1210/jc.2009-2791

Cavalier, E., Carlisi, I., Bekaert, A.-C., Rousselle, O., Delanaye, P., & Chapelle, J.-P. (June 2010). Evaluation of Liaison Calcitonin II Gen, a new kit for Calcitonin determination. Clinical Chemistry, 56 (S6), 188.

Cavalier, E., Daly, A., Betea, D., Pruteanu Apetrii, P., Delanaye, P., Stubbs, P., Bradwell, A. R., Chapelle, J.-P., & Beckers, A. (June 2010). The ratio of PTH as measured by third and second generation assays as a marker for parathyroid carcinoma. Clinical Chemistry, 56 (S6), 188.

Cavalier, E., Rousselle, O., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Evaluation of the DiaSorin Liaison 1-84 PTH Assay, a new automated immunoassay for the determination of the 3rd Generation PTH. Clinical Chemistry, 56 (S6), 56.

Cavalier, E., Saarbach, D., Bekaert, A.-C., Carlisi, I., Chapelle, J.-P., & Delanaye, P. (June 2010). Analytical validation of the Abbott Architect urine NGAL. Clinical Chemistry, 56 (S6), 96.

Cavalier, E. (08 May 2010). Détermination de la Vitamine D : quand et à qui prescrire ? Qui supplémenter et comment corriger une carence ? [Paper presentation]. 14ème Journée de Biologie Clinque, Bruxelles, Belgium.

Cavalier, E. (03 April 2010). Place du dosage de la vitamine D [Paper presentation]. 3èmes Journées Nationales de Biologie Praticienne, Tanger, Morocco.

Delanaye, P., Maillard, N., Rozet, E., Cavalier, E., Krzesinski, J.-M., Alamartine, E., & Mariat, C. (April 2010). Donor-Estimated Glomerular Filtration Rate as a Criterion for Allocation of Expended Criteria Donors Kidney into Single or Dual Transplantation : The Choice of the Estimating Equation Matters [Poster presentation]. American Society of Transplantation, San Diego, United States - California.

Cavalier, E. (05 March 2010). Methods for Vitamin D measurement - analytical problems and clinical relevance [Paper presentation]. 53 Symposion der Deutscehn Gesellschaft für Endokrinologie und Jahrestagung der Slowakischen Gesellschaft für Endokrinologie, Leipzig, Germany.

Gadisseur, R., & Cavalier, E. (02 March 2010). Laboratoire et allergologie : nouvelles applications [Paper presentation]. Colloque Hôpital André Renard, Herstal, Belgium.

Gadisseur, R., & Cavalier, E. (04 February 2010). Laboratoire et allergologie : nouvelles applications [Paper presentation]. Colloque CHPLT, Verviers, Belgium.

Cavalier, E. (2010). PARATHORMONE DETERMINATION IN THE CLINICAL LABORATORY: BIOCHEMICAL, CLINICAL AND ANALYTICAL ASPECTS [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/41253

Gadisseur, R., & Cavalier, E. (07 January 2010). Laboratoire et allergologie : nouvelles applications [Paper presentation]. Colloque de Pneumologie, Liège, Belgium.

Cavalier, E. (2010). La fonction rénale. (Biochimie pathologique y compris Chimie médicale, partim I).

Cavalier, E., Bekaert, A.-C., Legrand, D., Rozet, E., Krzesinski, J.-M., & Delanaye, P. (2010). Urinary NGAL: Use of absolute value or ratio to creatinine? Acta Clinica Belgica, 65-3, 13.

Cavalier, E., & Delanaye, P. (2010). Evaluation meets Precision. Sciencebook Europe, 1, 5.

Cavalier, E., Delanaye, P., Cormier, C., & Souberbielle, J.-C. (2010). Measurement uncertainty for the analysis of serum 25-hydroxyvitamin D: response to Stepman and Thienpont [letter to the editor]. Osteoporosis International, 21, 1055-1056. doi:10.1007/s00198-009-1098-4

Cavalier, E., Delanaye, P., & Krzesinski, J.-M. (2010). PTH reference target for the follow-up of hemodialyzed patients and new KDIGO guidelines: the end of a nightmare? Acta Clinica Belgica.

Cavalier, E., Saarbach, D., Bekaert, A.-C., Legrand, D., Krzesinski, J.-M., & Delanaye, P. (2010). Urinary or plasma NGAL?: Analytical point of view. Acta Clinica Belgica.

Delanaye, P., Cavalier, E., Maillard, N., Krzesinski, J.-M., Mariat, C., Cristol, J.-P., & Pieroni, L. (2010). La creatinine : d'hier a aujourd'hui. Annales de Biologie Clinique, 68 (5), 531-43. doi:10.1684/abc.2010.0479

Delanaye, P., Cavalier, E., Mariat, C., Maillard, N., & Krzesinski, J.-M. (2010). MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant? BMC Nephrology, 11 (8). doi:10.1186/1471-2369-11-8

Detry, O., Janssen, N., Cavalier, E., Delanaye, P., Cheramy-Bien, J.-P., Honore, P., Defraigne, J.-O., & Lambermont, B. (2010). Effects of large pore hemofiltration in a swine model of fulminant hepatic failure. Acta Gastro-Enterologica Belgica, 73 (1), 35.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (2010). Component-resolved-diagnosis and validation of an allergen-microarray technology. Allergy, 65 (suppl. 92), 93.

Gadisseur, R., Chapelle, J.-P., Cavalier, E., & Blanco-Catafal Anna, U. O. B. (Other coll.). (2010). Component-resolved diagnosis in peanut and hazelnut allergy. Allergy, 65 (Suppl.92), 106.

Gilson, N., Nsadi, B., Pire, E., Cheramy-Bien, J.-P., Pincemail, J., Cavalier, E., Le Goff, C., Defraigne, J.-O., Meurisse, M., & Detry, O. (2010). Consequences of laparoscopy on liver ischemia during portal triad clamping in a swine model. Acta Gastro-Enterologica Belgica, 73 (1), 13.

Greiner, C., Cavalier, E., Remy, B., Gabriel, A., Farnir, F., Gajewski, S., & Carstanjen, B. (2010). Bone Turnover During Pregnancy in Horses. Journal of Bone and Mineral Research, 25, 233.

Ho, T. T. G., Keutgens, A., Chapelle, J.-P., & Cavalier, E. (2010). Corrélation aldostérone et parathormone en cas d'hyperparathyroïdie primaire vs secondaire? Annales de Biologie Clinique, 68 (6), 703-4.

Souberbielle, J.-C., Cavalier, E., & Jean, G. (2010). Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory? Clinical Chemistry and Laboratory Medicine, 48 (6), 769-774. doi:10.1515/CCLM.2010.157

Gadisseur, R., & Cavalier, E. (17 December 2009). Laboratoire et allergologie : nouvelles applications [Paper presentation]. Symposium Société Liégeoise de Dermatologie, Liège, Belgium.

Gadisseur, R., & Cavalier, E. (11 December 2009). Laboratoire et allergologie : nouvelles applications [Paper presentation]. Colloque de pédiatrie, Liège, Belgium.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (19 November 2009). IMMUNOCAP© ISAC: INTEREST IN ALLERGY DIAGNOSIS [Poster presentation]. Symposium BVKB/SBBC, Mont-Godinne, Belgium.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (19 November 2009). CRD and technical validation of ImmunoCAPISAC [Paper presentation]. ImmunoCAP ISAC : First International Users Meeting, Diegem, Belgium.

CAVALIER, E. (02 October 2009). Vitamin D, Status and perspectives [Paper presentation]. Vitami D: hype or treat?, Amersfoort, Netherlands.

Cavalier, E. (2009). Vitamin D: status and perspectives [Paper presentation]. Vitamine D tekort: hype of bedreiging?, Amersfoort, Netherlands.

Mariat, C., Cavalier, E., Maillard, N., Krzesinski, J.-M., & Delanaye, P. (October 2009). Prevalence of Chronic Kidney Disease in an Elderly Population: Impact of the Choice of the Equation Used for Estimating GFR [Poster presentation]. American Society of Nephrology, San Diego, United States.

Cavalier, E. (2009). Gestion à distance de la biologie délocalisée: expérience du CHU de Liège [Paper presentation]. 4th International Symposium Blood Gases and Critical Care Testing, Belle-Ile en Mer, France.

Cavalier, E., Carlisi, I., Chapelle, J.-P., & Rozet, E. (June 2009). VALIDATION AND ACCURACY PROFILES OF THE LIAISON BAP_OSTASE (DIASORIN), A NEW METHOD FOR THE DETERMINATION OF BONE ALKALINE PHOSPHATASE. Clinical Chemistry and Laboratory Medicine, 47 (51).

Cavalier, E., Rozet, E., Carlisi, I., Bekaert, A.-C., Chapelle, J.-P., & Delanaye, P. (June 2009). ANALYTICAL PERFORMANCE OF THE C-TERMINAL FGF-23 (IMMUTOPICS). Clinical Chemistry and Laboratory Medicine, 47 (M-A032).

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (June 2009). A new diagnostic tool for in vitro allergy. Allergy, 64, 30-31.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (29 May 2009). Nouveaux outils de diagnostic in-vitro des allergies [Paper presentation]. Symposium CPALF, Mont-Godinne, Belgium.

Bouüaert, C., & Cavalier, E. (2009). La vitamine D dans tous ses états: épidémiologie de la déficience [Paper presentation]. 7èmes Journées de l'Enseignement post-universitaire de la Faculté de Médecine de Liège, Liège, Belgium.

Lecart, M.-P., & Cavalier, E. (2009). La vitamine D dans tous ses états: effets pleiotropes de la vitamine D [Paper presentation]. 7èmes Journées de l'Enseignement post-universitaire de la Faculté de Médecine de l'Université de Liège, Liège, Belgium.

Cavalier, E. (2009). Vitamin D: interest in non bone pathologies [Paper presentation]. 5th Euregio Conference on Clinical Chemistry and Laboratory Medicine, Liège, Belgium.

Gadisseur, R., Chapelle, J.-P., & Cavalier, E. (24 March 2009). Intérêt des allergènes recombinants: aspects biologiques [Paper presentation]. Jeudis de Fleurus, Haute Ecole Louvain en Hainaut, Fleurus, Belgium.

Gadisseur, R., & Cavalier, E. (02 March 2009). Microarrays destinés au diagnostic in-vitro des allergies [Paper presentation]. Glem de Biologie Clinique, Liège, Belgium.

Delanaye, P., Cavalier, E., Mariat, C., Maillard, N., Dubois, B., & Krzesinski, J.-M. (February 2009). Détection et estimation du niveau de la maladie rénale chronique. Revue Médicale de Liège, 64 (2), 73-78.

Gadisseur, R., & Cavalier, E. (30 January 2009). Microarrays for allergy [Paper presentation]. Symposium FOCUS Diagnostica, Anderlecht, Belgium.

Cavalier, E., Carlisi, I., Chapelle, J.-P., Orfanos, P., Uzan, M., Falque, V., Delanaye, P., & Hachicha, M. (2009). Human anti-mouse antibodies interferences in Elecsys PTH assay after OKT3 treatment. Transplantation, 87 (3), 451-2. doi:10.1097/TP.0b013e31819575a1

Cavalier, E., Delanaye, P., Carlisi, I., Chapelle, J.-P., & Collette, J. (2009). An unusual interference in parathormone assay caused by anti-goat IgG: a case report. Clinical Chemistry and Laboratory Medicine, 47 (1), 118. doi:10.1515/CCLM.2009.015

Cavalier, E., Delanaye, P., Chapelle, J.-P., & Souberbielle, J.-C. (2009). Vitamin D: current status and perspectives. Clinical Chemistry and Laboratory Medicine, 47 (2), 120-127. doi:10.1515/CCLM.2009.036

Cavalier, E., & Souberbielle, J.-C. (January 2009). La vitamine D : effets « classiques », « non classiques » et évaluation du statut du patient. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 33, 7-16. doi:10.1016/j.mednuc.2008.10.001

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (2009). Low prevalence of chronic kidney disease in Far-East Asian populations: impact of the ethnicity factor? [letter to the editor]. Nephrology Dialysis Transplantation, 24 (9), 2952-3. doi:10.1093/ndt/gfp279

Delanaye, P., Cavalier, E., Lambermont, B., Canivet, J.-L., Preiser, J.-C., Garweg, C., Dubois, B., Morimont, P., Wiesen, P., Bataille, Y., Damas, P., & Krzesinski, J.-M. (2009). Mesure du débit de filtration glomérulaire aux soins intensifs basée sur l’iohexol : clairance plasmatique ou urinaire ? [Poster presentation]. 37ème congrès de la Société de Réanimation de Langue Française, Paris, France.

Delanaye, P., Cavalier, E., Maillard, N., Mariat, C., & Krzesinski, J.-M. (2009). Prévalence de la maladie rénale chronique par l’estimation du DFG dans une population de plus de 50 ans selon la formule MDRD versus la nouvelle formule CKD-EPI [Poster presentation]. XI réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Toulouse, France.

DELANAYE, P., Cavalier, E., RORIVE, M., Paquot, N., SCHEEN, A., & KRZESINSKI, J.-M. (2009). Estimation de filtration glomérulaire chez le patient obese: performances des équations basées sur la créatinine et la cystatine C [Poster presentation]. 11e reunion commune de la Société Francophone de Dialyse (SFD) et de la société de Néphrologie (SN), Toulouse, France.

Delanaye, P., Cavalier, E., Rorive, M., Radermecker, R., Paquot, N., Scheen, A., & Krzesinski, J.-M. (2009). Estimation du debit de filtration glomérulaire chez le patient obese: performances des équations basées sur la créatinine et la cystatine C [Paper presentation]. réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Toulouse, France.

Delanaye, P., Cavalier, E., Rorive, M., Radermecker, R., Scheen, A., & Krzesinski, J.-M. (2009). Indexing glomerular filtration for body surface area is misleading in obese subjects: reductio ad absurdum [Poster presentation]. World Congress of Nephrology, Milano, Italy.

Delanaye, P., Cavalier, E., Saint-Remy, A., Lutteri, L., & Krzesinski, J.-M. (2009). Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population. Scandinavian Journal of Clinical and Laboratory Investigation, 69 (3), 344-9. doi:10.1080/00365510802609856

Delanaye, P., Mariat, C., Cavalier, E., & Krzesinski, J.-M. (2009). Indexation du debit de filtration glomerulaire par la surface corporelle : mythe et realite. Néphrologie et Thérapeutique, 5 (7), 614-22. doi:10.1016/j.nephro.2009.04.002

Delanaye, P., Mariat, C., Cavalier, E., & Krzesinski, J.-M. (2009). Errors induced by indexing glomerular filtration rate for body surface area: reductio ad absurdum. Nephrology Dialysis Transplantation, 24 (12), 3593-6. doi:10.1093/ndt/gfp431

Gadisseur, R., Cataldo, D., Collard, L., Chapelle, J.-P., & Cavalier, E. (2009). Allergie au venin d'hyménoptère et tests de laboratoires : de nouvelles approches pour la prise en charge des patients à haut risque de réaction sévère. Revue Médicale de Liège, 64 (11), 570-5.

Mistretta, V., Cavalier, E., Collette, J., & Chapelle, J.-P. (2009). Production des anticorps monoclonaux. Revue Médicale de Liège, 64 (5-6), 248-252.

Mistretta, V., Cavalier, E., Collette, J., Lutteri, L., & Chapelle, J.-P. (2009). Intérêt des anticorps monoclonaux dans le laboratoire d'analyses biomédicales. Revue Médicale de Liège, 64 (5-6), 257-263.

Cavalier, E., Péroni, L., Abshoff, C., Lutteri, L., Chapelle, J.-P., Krzesinski, J.-M., & Delanaye, P. (November 2008). Etude analytique des trois trousses de cystatine C et impact sur les formules basées sur la cystatine pour l'estimation du DFG. Néphrologie et Thérapeutique, 4 (6), 399-400.

Cavalier, E., Cormier, C., & Souberbielle, J.-C. (September 2008). Measurements of Vitamin D Do Not Necessarily Reflect What You Give to Your Patients. Journal of Bone and Mineral Research, 23, 196.

Cavalier, E., Delanaye, P., Carlisi, I., & Chapelle, J.-P. (September 2008). Analytical Validation of Diasorin Liaison and Roche Elecsys Methods for the Determination of Osteocalcin. Journal of Bone and Mineral Research, 23, 191.

Cavalier, E., Wallace, A. M., Knox, S., Mistretta, V., Chapelle, J.-P., & Souberbielle, J.-C. (September 2008). Circulating Concentrations of 25-Hydroxyvitamin D after a Single Oral Dose of 100.000 IU of Vitamin D2 or Vitamin D3. Journal of Bone and Mineral Research, 23, 212.

Cavalier, E., Carlisi, A., Chapelle, J.-P., & Delanaye, P. (January 2008). False positive PTH results: An easy strategy to test and detect analytical interferences in routine practice. Clinica Chimica Acta, 387 (1-2), 150-152. doi:10.1016/j.cca.2007.08.019

Cavalier, E., Delanaye, P., Morreale, A., Carlisi, I., Mourad, I., Chapelle, J.-P., & Emonts, P. (2008). La carence en vitamine d chez les femmes enceintes en region liegeoise: un probleme meconnu. Revue Médicale de Liège, 63 (2), 87-91.

Cavalier, E., Rozet, E., Dubois, N., Charlier, C., Hubert, P., Chapelle, J.-P., Krzesinski, J.-M., & Delanaye, P. (2008). Performance of iohexol determination in serum and urine by HPLC: validation, risk and uncertainty assessment. Clinica Chimica Acta, 396, 80-85. doi:10.1016/j.cca.2008.07.011

Cavalier, E., Wallace, A. M., Mistretta, V., & Souberbielle, J.-C. (2008). Misdiagnosis of vitamin D insufficiency in subjects who received vitamin D2. Clinical Chemistry, 54 (6), 110.

Delanaye, P., Cavalier, E., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2008). New data on the intraindividual variation of cystatin C. Nephron. Clinical Practice, 108 (4), 246-8. doi:10.1159/000124327

Delanaye, P., Cavalier, E., Froissart, M., & Krzesinski, J.-M. (2008). Reproducibility of GFR measured by chromium-51-EDTA and iohexol [letter to the editor]. Nephrology Dialysis Transplantation, 23 (12), 4077-8; author reply 4078. doi:10.1093/ndt/gfn496

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (2008). Cystatin C, renal function, and cardiovascular risk [letter to the editor]. Annals of Internal Medicine, 148 (4), 323. doi:10.7326/0003-4819-148-4-200802190-00023

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (2008). Chronic kidney disease in Taiwan [letter to the editor]. The Lancet, 372 (9654), 1950; author reply 1950-1. doi:10.1016/S0140-6736(08)61836-X

Delanaye, P., Cavalier, E., Krzesinski, J.-M., & Mariat, C. (2008). Cystatin C-based equations: don't repeat the same errors with analytical considerations [letter to the editor]. Nephrology Dialysis Transplantation, 23 (3), 1065; author reply 1065-6. doi:10.1093/ndt/gfm832

Delanaye, P., Cavalier, E., Maillard, N., Krzesinski, J.-M., & Mariat, C. (2008). Creatinine calibration in NHANES: is a revised MDRD study formula needed? [letter to the editor]. American Journal of Kidney Diseases, 51 (4), 709; author reply 709-10. doi:10.1053/j.ajkd.2007.12.041

Delanaye, P., Cavalier, E., Radermecker, R., Paquot, N., Depas, G., Chapelle, J.-P., Scheen, A., & Krzesinski, J.-M. (2008). Cystatin C or Creatinine for Detection of Stage 3 Chronic Kidney Disease in Anorexia Nervosa. Nephron. Clinical Practice, 110 (3), 158-c163. doi:10.1159/000166607

Delanaye, P., Cavalier, E., Saint-Remy, A., Dechenne, C., & Krzesinski, J.-M. (2008). Prevalence of chronic kidney disease in Province of Liège: critical comparison with the American NHANES study? [Paper presentation]. Réunion de la Société Belge de Néphrologie, Leuven, Belgium.

Delanaye, P., Cavalier, E., Saint-Remy, A., Dechenne, C., & Krzesinski, J.-M. (2008). Prévalence de la maladie rénale au stade 3 selon l’équation MDRD : comparaison critique des données liégeoises (Belgique) et américaines (étude NHANES) [Poster presentation]. 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Delanaye, P., Cavalier, E., Saint-Remy, A., Lutteri, L., Chapelle, J.-P., & Krzesinski, J.-M. (2008). Prévalence de la maladie rénale chronique par l’estimation du DFG avec une formule basée sur la créatinine versus la cystatine C [Poster presentation]. 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Delanaye, P., Pieroni, L., Abshoff, C., Lutteri, L., Chapelle, J.-P., Krzesinski, J.-M., Hainque, B., & Cavalier, E. (2008). Analytical study of three cystatin C assays and their impact on cystatin C-based GFR-prediction equations. Clinica Chimica Acta, 398 (1-2), 118-24. doi:10.1016/j.cca.2008.09.001

Gadisseur, R., Collard, L., Cataldo, D., Chapelle, J.-P., & Cavalier, E. (2008). Can laboratory tests help to define the profile of desensitised patients or patients at high risk of severe reaction ? Allergy, 63 (Suppl. 88), 1773.

Mistretta, V., Delanaye, P., Chapelle, J.-P., Souberbielle, J.-C., & Cavalier, E. (2008). Vitamine D2 ou vitamine D3? Revue de Médecine Interne, 29 (10), 815-20. doi:10.1016/j.revmed.2008.03.003

Monfort, M., Delanaye, P., Chapelle, J.-P., & Cavalier, E. (2008). Calcium chez les patients hemodialyses : calcemie totale ou calcium ionise ? Le laboratoire doit-il systematiquement fournir au clinicien une valeur de calcemie totale corrigee obtenue par calcul ? Annales de Biologie Clinique, 66 (5), 573-6. doi:10.1684/abc.2008.0264

Piéroni, L., Delanaye, P., Abshoff, C., Lutteri, L., Chapelle, J.-P., Hainque, B., Krzesinski, J.-M., & Cavalier, E. (2008). Impact de la stabilité de la cystatine C sur la validité des mesures dans les études rétrospectives [Poster presentation]. 10ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Marrakech, Morocco.

Séronie-Vivien, S., Piéroni, L., Galteau, M.-M., Carlier, M.-C., Cavalier, E., Hanser, A.-M., & Cristol, J.-P. (2008). Evolution des modalités d'évaluation de la fonction rénale basée sur la créatinine entre 2005 et 2008: conséquences pour les biologistes. Annales de Biologie Clinique, 66 (3), 263-8. doi:10.1684/abc.2008.0226

Souberbielle, J.-C., Prié, D., Courbebaisse, M., Friedlander, G., Houillier, P., Maruani, G., Cavalier, E., & Cormier, C. (2008). Actualite sur les effets de la vitamine D et l'evaluation du statut vitaminique D. Annales d'Endocrinologie, 69 (6), 501-10. doi:10.1016/j.ando.2008.07.010

Lognard, M., Cavalier, E., Chapelle, J.-P., Lambermont, B., Krzesinski, J.-M., & Delanaye, P. (19 December 2007). Acetylcysteine and Enzymatic Creatinine: Beware of Laboratory Artefact! [letter to the editor]. Intensive Care Medicine, 34 (5), 973-974. doi:10.1007/s00134-007-0972-9

Katsanos, K., Cavalier, E., Ferrante, M., Schnitzler, F., Katsaraki, A., Noman, M., Vermeire, S., Epameinondas, V. T., Rutgeerts, P., Chapelle, J.-P., & Van Assche, G. (December 2007). Intravenous iron therapy restores functional iron deficiency induced by infliximab. Journal of Crohn's and Colitis, 1, 97-105. doi:10.1016/j.crohns.2007.08.005

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (September 2007). Impact des conditions préanalytiques sur le dosage de la PTH. Néphrologie et Thérapeutique, 3 (5), 192.

Cavalier, E., Delanaye, P., Carlisi, A., Krzesinski, J.-M., & Chapelle, J.-P. (August 2007). Stability of intact parathyroid hormone in samples from hemodialysis patients. Kidney International, 72 (3), 370-372. doi:10.1038/sj.ki.5002363

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (June 2007). PTH stability : preanalytical conditios influences for Liaison (Diasorin). Clinical Chemistry and Laboratory Medicine, 45.

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (June 2007). Evaluation of heterophile antibodies interference on Liaison PTH (Diasorin). Clinical Chemistry and Laboratory Medicine, 45.

Cavalier, E., & Delanaye, P. (24 March 2007). Equations for GFR estimation: application and limits [Paper presentation]. 3rd Euregio conference of clinical chemistry and laboratory medicine, Vaals, Netherlands.

Cavalier, E., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (23 March 2007). MDRD equation for GFR estimation : analytical limitations [Paper presentation]. 10th International Symposium of Nephrology at Montecatini, Montecatini Terme, Italy.

Delanaye, P., Nellessen, E., Cavalier, E., Depas, G., Grosch, S., Defraigne, J.-O., Chapelle, J.-P., Krzesinski, J.-M., & Lancellotti, P. (15 March 2007). Is cystatin C useful for the detection and the estimation of low glomerular filtration rate in heart transplant patients? Transplantation, 83 (5), 641-644. doi:10.1097/01.tp.0000253746.30273.cd

Cavalier, E., Delanaye, P., Ferir, A.-M., Krzesinski, J.-M., & Chapelle, J.-P. (February 2007). Measurement uncertainty of creatinine in low values: Another good reason not to use the MDRD formula with low creatinine values. Clinical Biochemistry, 40 (3-4), 285-286. doi:10.1016/j.clinbiochem.2006.10.021

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (02 January 2007). Estimated glomerular filtration rate [letter to the editor]. Annals of Internal Medicine, 146 (1), 74-74. doi:10.7326/0003-4819-146-1-200701020-00020

Cavalier, E., Delanaye, P., Carlisi, A., Krzesinski, J.-M., & Chapelle, J.-P. (2007). Analytical validation of the new version of the Liaison N-Tact PTH assay. Clinical Chemistry and Laboratory Medicine, 45 (1), 105-107. doi:10.1515/CCLM.2007.017

Delanaye, P., Cavalier, E., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2007). Variabilité du débit de filtration glomérulaire, de la créatinine et de la cystatine C plasmatiques [Poster presentation]. 9ème réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lyon, France.

Delanaye, P., Cavalier, E., & Krzesinski, J.-M. (2007). Impact of creatinine calibration in the MDRD equation on the epidemiology of renal failure [Paper presentation]. Réunion de la Société Belge de Néphrologie, Bruxelles, Belgium.

Delanaye, P., Krzesinski, J.-M., Cavalier, E., & Lambermont, B. (2007). The RIFLE criteria: are the foundations robust? [letter to the editor]. Critical Care Medicine, 35 (11), 2669; author reply 2669-70. doi:10.1097/01.CCM.0000288115.09689.3C

Goffinet, J., Bernard, P., Cavalier, E., & Chapelle, J.-P. (2007). Evaluation of the new BRAHMS-Biomerieux quantitative test for procalcitonin determination. Acta Clinica Belgica, 62 (6), 463-463.

Lognard, M., Cavalier, E., Chapelle, J.-P., Lambermont, B., Krzesinski, J.-M., & Delanaye, P. (2007). Acetylcysteine and enzymatic creatinine: take care for interference! Acta Clinica Belgica, 62 (6), 462-462.

Cavalier, E. (November 2006). Glycémie délocalisée: Entretien avec le Dr Etienne CAVALIER. Biotribune Magazine, 19 (1), 33.

Delanaye, P., Cavalier, E., Chapelle, J.-P., Krzesinski, J.-M., & Froissart, M. (November 2006). Renal extraction of cystatin C [letter to the editor]. Nephrology Dialysis Transplantation, 21 (11), 3333-3333. doi:10.1093/ndt/gfl324

Cavalier, E., Delanaye, P., Carlisi, I., Krzesinski, J.-M., & Chapelle, J.-P. (2006). PTH oxidation after a session of hemodialyze: myth or reality? Immuno-Analyse and Biologie Spécialisée.

Cavalier, E., Levaux, L., Carlisi, I., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (2006). VALIDATION ANALYTIQUE DE LA TROUSSE OCTEIA 25-HYDROXYVITAMINE D (IDS). Immuno-Analyse and Biologie Spécialisée.

Cavalier, E., Delanaye, P., Collette, J., Krzesinski, J.-M., & Chapelle, J.-P. (September 2006). Evaluation of different bone markers in hemodialyzed patients. Clinica Chimica Acta, 371 (1-2), 107-111. doi:10.1016/j.cca.2006.02.029

Delanaye, P., Cavalier, E., Chapelle, J.-P., & Krzesinski, J.-M. (April 2006). Importance of the creatinine calibration in the estimation of GFR by MDRD equation [letter to the editor]. Nephrology Dialysis Transplantation, 21 (4), 1130-1130. doi:10.1093/ndt/gfl038

Cavalier, E., Carlisi, A., & Chapelle, J.-P. (2006). Validation analytique de l'ImmunoCap 250 (Sweden Diagnostics). Annales de Biologie Clinique, 64 (1, Jan-Feb), 91-4.

Delanaye, P., Cavalier, E., Radermecker, R., Paquot, N., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2006). Estimation du débit de filtration glomérulaire par les formules basées sur la créatinine et la cystatine C en cas d’anorexie mentale [Paper presentation]. 8éme réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Lille, France.

Delanaye, P., Cavalier, E., Radermecker, R., Rorive, M., Depas, G., Chapelle, J.-P., & Krzesinski, J.-M. (2006). Plasma cystatin C for the detection of renal failure in obese patients [Poster presentation]. 43ème Congress of ERA-EDTA, Glasgow, United Kingdom.

Delanaye, P., Nellessen, E., Grosch, S., Depas, G., Cavalier, E., Defraigne, J.-O., Chapelle, J.-P., Krzesinski, J.-M., & Lancellotti, P. (2006). Creatinine-based formulae for the estimation of glomerular filtration rate in heart transplant recipients. Clinical Transplantation, 20 (5, Sep-Oct), 596-603. doi:10.1111/j.1399-0012.2006.00523.x

Meex, C., Poncin, J., Chapelle, J.-P., & Cavalier, E. (2006). Analytical validation of the new plasma calibrated Accu-Chek (R) Test Strips (Roche Diagnostics). Clinical Chemistry and Laboratory Medicine, 44 (11), 1376-1378. doi:10.1515/CCLM.2006.249

Cavalier, E., Delanaye, P., Krzesinski, J.-M., & Chapelle, J.-P. (2005). Comparison of liaison N-tact PTH (diasorin) and N-tact PTH SPIRMA (diasorin) in hemodialyzed patients [letter to the editor]. Clinical Chemistry and Laboratory Medicine, 43 (8), 890-891. doi:10.1515/CCLM.2005.151

Marcelis, M., Cavalier, E., Gielen, J., Delespaul, P., & Van Os, J. (August 2004). Abnormal response to metabolic stress in schizophrenia: marker of vulnerability or acquired sensitization? Psychological Medicine, 34 (6), 1103-1111. doi:10.1017/S0033291703001715

Marcelis, M., Cavalier, E., Gielen, J., Delespaul, P., & van Os, J. (2002). Metabolic stress as a paradigm to elucidate genotype-environment interaction in psychosis. Acta Psychiatrica Scandinavica, 105 (Suppl. 411), 91.